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INTRODUCTION 
Health of an individual is assessed by the way a person who leads his life. This 
means not only the physical activities of a person but also the mental makeup. In recent 
times due to life style modifications, lot of dreadful changes have started occurring in an 
individual’s physical and mental health which can cause hindrance to the progress of a 
person’s day to day activities.   
The Siddha system can provide longevity, even immortality to the society through 
yoga and medicines prepared from meticulously processed minerals, herbal extracts and 
their rejuvenating compositions, etc.  
Siddhar Yugi Munivar in his Yugivaithiya Chinthamani 800 described about 80 
types of Vaatha diseases. KumbaVaatham is one among them. As per his poem symptoms 
of kumba vaatham are pain in the shoulders, arms, burning sensation in the eyes, 
benumbed feeling in the neck and giddiness, Dizziness. These symptoms may be 
correlated with that of periarthiritis shoulder in modern science. 
The  main symptoms of the Periarthritis shoulder are  acute shoulder pain, restricted 
movements in upper limb,  loss of abduction and  forward flexion followed by stiffness of the 
shoulder joint. 
 The estimated prevalence of frozen shoulder is 2%–3% in the general population and 
5%–6% in patients evaluated by shoulder surgeons . Age incidence range from 40 to 70 year, 
predominantly females are affected 
Surgery is one of the treatment options for peri arthritis shoulder in Allopathic 
system. So the people are in search for a treatment which is free from side effects and can 
cure the disease.  
The Internal drug Parangipattai  rasayanam is a Herbal preparation. It wont cause 
any side effects. Most of the drugs in lasunathy thylam which is used for external 
application have Anti –Vaatha property.   
 So a  preclinical and clinical  study on the kumbavaatham ( periarthritis shoulder ) 
and the drug of choice is  parangipattai  rasayanam ( internal ) and lasunathy  thaylam         
( external ) has been framed to find out the safty and efficacy of the internal and external 
medicines in the treatment of kumbavaatham ( periarthritis shoulder ) 
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AIM AND OBJECTIVES 
AIM: 
 The principle aim of the present study is to evaluate the safety and therapeutic 
efficacy of the Siddha formulation PARANGIPATTAI RASAYANAM (INTERNAL)  
and LASUNATHY THAILAM (EXTERNAL). 
 
OBJECTIVES 
1.PRIMARY OBJECTIVE : 
To evaluate the therapeutic efficacy of the Siddha formulation “Parangipattai 
rasayanam” (Internal Medicine) and Lasunathy thaylam (external). in the treatment of 
“kumbavaatham” (Periarthritis shoulder) 
 
2. SECONDARY OBJECTIVE : 
1. To Botanical identification and authentication of the trial drug. 
2. To prepare the trial drug PARANGIPATTAI  RASAYANAM as per Siddha 
literature and analysis of qualitative and quantitative constituents present in 
the trial drug. 
3. To establish the safty profile by performing acute oral toxicity studies and sub 
acute toxicity studies on mice and rats following WHO guidelines. 
4. To analyze the prevalence of kumbavaatham among the society through Age, 
Sex, Occupation, Distribution etc. 
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                                     SIDDHA ASPECTS 
      பவாத  
DEFINITION: 
Kumbavaatham is a condition presenting with the symptoms like pain in the 
shoulder, arms, burning sensation in the eyes and cheeks, pain below the umbilicus (or) 
subnavel region, inflamed posterior aspect of tongue, benumbed feeling in the neck and 
giddiness, Dizziness. It has been classified under eighty types of vaathaa diseases. 
 
AETIOLOGY: 
The common aetiological factors for all types of vaatha diseases including 
kumbavaatham have been described generally in Yugi Vaidhya Chinthamani-800 and 
Agasthiyar Gunavagadam. 
In Yugi Vaidhya Chinthamani, the following causes have been given, 
 “¾¡¦ÉýÈ ¸ºô§À¡Î ÐÅ÷ôÒ¨ÈôÒ 
º¡¾¸Á¡ö ¦¿ïÍ¸¢ õ º¨Áò¾ Åñ½õ 
¬¦ÉýÈ Å¡È¢ÉÐ ¦À¡º¢ò¾Ä¡Öõ 
¬¸¡Âò§¾ÈÄÐ ÌÊò¾Ä¡Öõ 
À¡¦ÉýÈ À¸ÖÈì¸ Á¢Ã¡ Å¢Æ¢ôÒ 
ÀðÊÉ¢§Â Á¢¸×Ú¾ø À¡Ã¦Áö¾ø 
§¾¦ÉýÈ ¦Á¡Æ¢Â¡÷ §Áüº¢ó¨¾Â¡¾ø 
º£ì¸¢ÃÁ¡ö Å¡¾Á¢Ð ¦ºÉ¢ìÌó¾¡§É” 
“À¸Ã§Å Å¡¾ÁÐ §¸¡À¢ò¾ô§À¡ 
ÀñÀ¡¸ ¦Àñ§À¡¸ ÁÐ¾¡ý 
¿¸Ã§Å ¦ÅÌàÃÅÆ¢ ¿¼ì¸¢ø 
¿Ç¢Ã¡É ¸¡üÚ§Á ÀÉ¢§ÁüÀð¼¡ø 
Á¢¸Ã§Å ¸¡ö¸û ¸É¢¸¢ÆíÌ ¾ý¨É 
Á¢¸ÅÕò¾¢ Á£È£§Â ¾Â¢÷¾¡ý ¦¸¡ñ¼¡ø 
Ó¸Ã§Á ÓÐ¦¸Öõ¨À ÓÚì¸¢ ¦¿¡óÐ  
ÓÆí¸¡Öõ ¸¨½ì¸¡Öõ ¸ÎôÒ ¯ñ¼¡§Á” 
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· Consumption of bitter, astringent and pungent food items excessively 
· Eating food cooked on the previous day 
· Drinking polluted water 
· Changing sleep rhythm  
· Excessive starvation 
· Lifting heavy weight 
· Excessive lust 
· Sexual indulgence 
· Walking long distance 
· Living in chill environment 
· Excessive consumption of tubers, fruits, curd, etc 
· Pain in both knee and ankle joint. 
 
Vali (Vaatham) 
Vali is soft, fine and the temperate (coolness and hotness) which could be felt by 
touch. 
 
The sites of vali 
According to Vaithya Sathakam, vali dwells in the following places: 
 
       " ¦¾Ç¢ó¾¢ð¼ Å¡¾ÁÀ¡Éò¨¾ô ÀüÈ¢ 
       ¿¢¨Èó¾¢¨¼¨Âî §º÷óÐó¾¢ì ¸£§Æ ¿¢ýÚ 
        ÌÇ¢ó¾¢ð¼ ã¼Áà ¦¼ØóÐ ¸¡Áì 
            §¸¡ÊÂ¢¨¼¨Âô ÀüÈ¢¦ÂØí ¦È¡ì¨¸ ¿¡Ê 
          ¿¢½Á¡É ¦À¡Õò¾¢¼Óõ §Ã¡Áì ¸¡Öõ  
            ¿¢¨ÈÅ¡¸¢ Á¡í¸¢º¦Áø Ä¡õÀÃóÐ" 
                                   -¨Åò¾¢Â º¾¸õ 
 Umbilicus, Rectum, Faecal matters, Abdomen, Anus, Bones, Hip joints, Navel      
           Plexus, Joints, Hair follicle and Muscles. 
       
 
5 
 
      "«È¢ó¾¢Îõ Å¡¾ Á¼íÌ ÁÄò¾¢É¢ø" 
                                    -¾¢ÕãÄ÷ 
  "¿¡¦ÁýÈ Å¡¾òÐì ¸¢ÕôÀ¢¼§Á §¸Ç¡ö 
    ¿¡À¢ìÌì ¸£¦ÆýÚ ¿Å¢Ä Ä¡Ìõ" 
                              -ä¸¢ 
      According to Sage Yugi muni, the location of Vaatham are the anus  and the sub 
neval region. 
  பவாத : 
நவ லேவ ேதா ம   கர தி  ம   
நலி   ெம தவாகி ேயேநா   டா   
கவ லேவ க னெமா  நயன  தா   
க   ேம வ வ    ெம    கா   
 வ லேவ    பா   சிர  த ன  
 ழ றிேய நாப கீ  வலி    டா  
அவ லேவ ய நா கி லழ   கா   
அல ேம வ ேம வ   ப வாத  தாேன. 
 
- கி ைவ திய சி தாமண  800 
 
 
Clinical Features: 
 
 
· Pain in the shoulder, arms 
· Burning sensation in the eyes 
· Benumbed feeling in the neck 
· Giddiness 
· Dizziness 
 
Properties of Vali:      
 
  "´ØíÌ¼ý ¾¡§¾ú ãî§º¡í¸¢ þÂí¸ 
      ±Øîº¢¦ÀÈ ±ôÀ½¢ÔÁ¡üÈ ²Øó¾¢Ã¢Â 
   §Å¸õ ÒÄý¸ÙìÌ §ÁÅî ÍÚÍÚôÒ 
      Å¡¸Ç¢ìÌõ Á¡ó¾÷ìÌ Å¡Ô" 
                            -º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ 
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 The following are the natural properties of vali 
1) To stimulate the respiration 
2) To activate the body, mind and the intellect. 
3) To activate the fourteen different types of natural reflexes. 
4) To activate the seven physical constituents in functional co- ordination. 
5) To strengthen the five sense organs. 
In the above process Vaatham plays a vital role in assisting the body functions. 
vaatha diseases:  
According to Theran vagadam:  
Loss of appetite, pain and redness, fever and cough, insomnia, Shivering, pain in  
all joints of the body are the characters of vadha disease. This was mentioned as:  
 
"thjtPW  md;dkpwq;fhJ  fLg;Gz;lhk;  tz;zKz;lhk;  
NkhJfl;L  Nuhfk; RuKz;lh  kpUkYkh  Kwq;fhnjd;Wk;  
xJRhpa  thj  kdyhF  eLf;f  Kz;lhk;  nghUs;fsha;j;  
jPjdNt  euk;gprpj;J  re;Jfs; NjhWk;  fLf;Fe; jpdKk;jhNd".  
 
-  Njud;  thflk;.  
According to Agasthiyar Aayul vedham 1200:  
 
Head ache, tremors of the body, insomnia, pallor, giddiness, numbness in both  
upper limbs and lower limbs are mentioned as the characters of vaatha disease. That is  
explained in the below verse,  
"nka;Na  eLq;Fe; jiytypf;F 
Nkdp  ntSf;Fq;  fz;Jhq;Fk; 
ngha;NaJq;  fpWfpWf;Fk 
Ngj  eadnka;  newpAq; 
iffhy; jpkph;e;J  Tyh;j;jptw;Wk; 
fz;Z  %f;FQ; rd;dp  fl;L 
ikahnka;A  kpfTdsthk; 
thjNuhf  FzkpJNt" 
mfj;jpah; MAs; Ntjk; 1200  
Diagnosis in Siddha: 
Piniyari muraigal (Method of Diagnosis) is based upon three main principles, 
Poriyal Arithal 
Pulanal Arithal 
Vinaathal   
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UDAL KATTUGAL: 
 
Our body consists of seven udal kattukal. They give strength and structure to our 
body. 
In kumbavaatham, oon, Kozhuppu and Enbu thathukkal are commonly affected.            
 
IMPORIGAL:  
Gnanenthiriyam are mei, vaai, kan, mooku and sevi. 
In kumbavaatham no abnormalities are seen in gnanenthiriyam. 
KANMENTHIRIYAM:  
Kanmenthiriyam are kai, kaal, vaai, eruvaai, karuvai. 
In kumbavaatham “kai” is affected. There will be pain and swelling, stiffness, restricted 
movements of the shoulder joints. 
 
 
ENVAGAI THERVUGAL (Eight diagnostic Tools): 
       It is a unique method of diagnosis in Siddha system of medicine. They are clearly 
explained by Siddhar Theraiyar as below, 
 
"¿¡Ê ŠÀÃ¢ºõ ¿¡ ¿¢Èõ ¦Á¡Æ¢ Å¢Æ¢ 
          ÁÄõ ãò¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ" 
                          - §¾¨ÃÂ÷ 
1. Naadi (Pulse): 
   In kumbavaatham the following Naadi can be seen commonly.  
  Vaathapitham, Pithavaatham 
 
2. Sparism (Sensation to touch): 
In kumbavaatham mild warmth noticed over the affected joint. 
3. Naa (Tongue): 
In kumbavaatham no abnormality is seen in Naa. 
4. Niram(Colour): 
 In kumbavaatham no abnormality is seen in Niram. 
5. Mozhi (Voice): 
In kumbavaatham no abnormality is noted in voice. 
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6. Vizhi (Eyes): 
In kumbavaatham no abnormality is noted in eyes. 
7. Malam (Faeces): 
In kumbavaatham constipation was reported in some cases. 
8. Moothiram (Urine): 
In urine (Moothiram) Neerkkuri and Neikkuri (Oil on urine sign) examinations are 
also done. 
Urine is examined for the following neerkkuri: 
Ø  Niram     -  Colour  
Ø  Edai         - Specific Gravity 
Ø  Manam   -  Smell 
Ø  Nurai       - Frothy nature 
Ø  Enjal        -  Quantity of urine voided 
Apart from these, frequency of urination, abnormal constituents, such as sugar, 
protein, presence of blood, pus, presence of crystals also to be found out.     
Naadi (Pulse): 
Naadi is the first and foremost diagnostic parameter of the Siddhars. It is the seat 
anchor of energy. The pulse wave as felt on the radial artery, one inch from the wrist by 
means of palpation with the tip of index, middle and ring finger corresponds to Vaatham, 
Pitham and Kabam. They normally exist in the ratio 1:1/2:1/4 respectively. 
 In kumbavaatham  the following types of Naadi can be commonly seen.They are  
Ø Vaathapitham 
Ø Pithavaatham 
 
                 Å¡¾ À¢ò¾ ¿¡Ê 
         "¦À¡ÕÇ¡É Å¡¾ò¾¢ø À¢ò¾ï §º÷óÐ 
               ¦À¡ÕóÐ Ì½í¸Ç¡ Ó‰½Å¡Ô ºò¾¢ 
          ¦ºÃ¢Â¡¨Á ÒÇ¢ò§¾ôÀõ ¦À¡ÕÁø ¿£Ã¢ü 
               º¢ÅôÒÁÄõ À¢Êò¾ÖÕó ¾¡Ð ¿ð¼õ 
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          ¸ÕÅ¡É §¾¸Á¾¢ Ö¨Çîºø §º¡õÀø 
               ¨¸¸¡ø ¾È¢ôÒ¿¡ì ¸ºìÌ ÁýÉõ 
          ÀÃ¢Å¡É °ñÌ¨È¾ø Õº¢§¸ ¼¡¾ø 
               ÀÄ §¿¡Ôõ ÅÕò¾¢¨ÅìÌõ À¡íÌ ¾¡§É" 
                                            - º¾¸ ¿¡Ê 
              À¢ò¾ Å¡¾¿¡Ê 
 
        º¢ÈôÀ¡É À¢ò¾ò¾¢ø Å¡¾¿¡Ê 
           §ºÃ¢ÖÚó ¾¡Ð ¿ð¼ Ó¾ÃÀ£¨¼ 
        ¯¨ÈôÀ¡¸î ¦ºÃ¢Â¡¨Á ÌýÁïÝ¨Ä 
           ¯üÈ ÍÃí ¸¢Ã¡½¢ ÅÂ¢üÈ¢¨Ãîºø Áó¾õ 
       «¨ÈôÀ¡É §Å¡í¸¡Ãô ÒÈ¿£÷ì§¸¡¨Å 
          ¬Â¡ºí ¸¢Úì§¸¡Î Áì¸ ã÷î¨º 
       Ó¨Èì¸¡ö× Å¢¼Å£ì¸õ ãÄÅ¡ö× 
          ÓÃ¼¡É §¿¡ö ÀÄ× ÓÎÌõ Àý§À. 
                                         - º¾¸ ¿¡Ê 
NOI KANIPPU VIVAATHAM (DIFFERENTIAL DIAGNOSIS): 
Some other types of vaatha diseases mimic kumbavaatham. Careful, clear history 
taking and examination will reveal the diagnosis. They are: 
1. Paei vaatham  
2. Cegana vaatham 
3. Kazhuththu vaatham 
4. Kurisa kirisavaatham. 
The clinical features of above diseases are mentioned in literatures as below: 
Paei Vaatham: 
“¦ÀüÈ¢Â¡õ ¦ÀÕ¨ÁÂ¡í ¸¡Öí ¨¸Ôõ 
¦ÀÕÅÂ¢Ú ¦¿ï§º¡Î Å¢ÃÖ ãìÌõ 
²üÈ¢Â¡ ¦ÁÈ¢¸ØòÐ ¦ÁíÌõ ÀüÈ¢ 
²ì¸Á¡ö ¦¿¡óÐ¼×õ ¦ÀíÌõ Å£í¸¢ 
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¯üÈ¢Â¡ ã½§Å ¿¢Á¢÷ò¦¾ÎòÐ 
¯Ú¾¢Â¡öô À¢Êì¸× ¦Á¡½¡Ä¡Ìõ 
ºì¾¢Â¡ö Å¡ö ¸ºóÐ ÁÂì¸Á¡Ìó 
¾¡¢ò¾¢¼ ¦Å¡ñ ½¡Ð §ÀöÅ¡¾ó ¾¡§É” 
· Pain and swelling in the abdomen, upper and lower limbs 
· Numbness (or) Weakness of hand muscles, difficulty in holding things in the 
hand. 
· Vomiting  
· Giddiness 
· Swelling all over the body 
Cegana vaatham : 
“§¸Ù§Á ¸Øò¾¢ý ¸£Æ¨ÃìÌ §ÁÖí 
¦¸ÊÂ¡É ¸ÃÁ¢ÃñÎ Á¢¸§Å ¦¿¡óÐ 
Å¡Ù§Á º¡£Ã¦ÁÄ¡í ¸Éò¾¢ÕìÌõ 
Å¡Ä¢À÷ìÌ ÁÉí¸ñÏ ÁÂì¸Á¡Ìõ 
²Ù§Á Â¢ÃñÎ¸ñÏ ¦Á¡¢îºÖñ¼¡ 
§ÁüÈÁ¡ö ºÄó¾¡Û Á¢Ú¸¢ì ¸¡Ïó 
§¾Ù§Á ¦¸¡ðÊÉÐ §À¡üì ¸ÎìÌõ 
º¸ÉÅ¡ ¾ò¾¢É¢¼ ¾£÷ì¸ó¾¡§É” 
- ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
· Pain in the neck to Lumbar region 
· Radiating pain in the shoulders and upper limbs 
· Heaviness of the body 
· Mental depression 
· Giddiness 
· Burning sensation of the eyes 
· Increased urine output. 
Kazhuththu Vaatham (Kooni Kiraga Vaatham): 
“¸Øò¨¾ ¾¢ÕôÀ¡§¾ À¢ÊòÐ 
¸¾¢¡¢ðÎ ¯¨Çó¾¡÷ §À¡§Ä ¸¡Ïõ 
¦ºÆ¢ò§¾ ¿ÃõÒ ¾ÊòÐ ¿¢üÌõ 
º£Ã¡¸ «¨ºì¸ ¦Å¡ð¼¡Ð 
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þØò§¾ À¢ÊòÐ þÃ¡ôÀ¸Öõ 
þ¼§Ã ¦ºöÔõ ¸ØòÐ Å¡¾õ 
ÅØòÐõ Ì½í¸û ¾Ã½¢ ¾ýÉ¢ø 
Å¨ºÂ¡ö «È¢Å£÷ ÀñÊ¾§Ã” 
- Å¡¾§¿¡ö ÁÕòÐÅõ 
· Stiffness and restriction of movements of the neck 
· Burning pain in neck  
· Thickening of nerves in neck  
· Symptoms continue day and night 
Kurisa kirisa vaatham: 
 
         “º¢ÈôÀ¡É À¡õÒÅ¢¼õ §À¡Ä ²È¢î 
             ¦ºÈ¢Å¡¸ Å¢Èí¸¢Â§¾¡÷ ¦ºö¨¸ §À¡Öó 
          ÐÈôÀ¡É Ý¨ÃÂ¡ Â¨ÃÂ¢ü Èð¨¼î 
             ÍÆÄ§Å ÍÕì¸¢¾¡ý ÀüÈ¢ Âí¸õ 
          À¢ÈôÀ¡É À£È¢Â§¾¡÷ Ì¼¨Äô §À¡Ä 
             À¢¾¢÷¸¢ýÈ Åý§À¡Öõ À¢ÃÁ¢ ¦ÂýÉ 
          Á¢ÈôÀ¡É §¾¡Ä¢øÓû ¦À¡¾¢ó¾¡ü §À¡Ä 
ÓÂýÈ¢Îí ¸¡ñÌÃ¢º ¸¢Ã¢º ã÷ì¸ó ¾¡§É.” 
- சி த ம   வ  ெபா  
· Pain in groin  
· Pricking pain in shoulder 
LINE OF TREATMENT: 
In Siddha system the treatment is mainly based upon the Mukkuttram principle. 
Treatment is not only for perfect cure but also for the prevention of diseases and 
rejuvenation of udal kattukkal. The physician’s duty is to diagnose the disease, trace the 
etiology and choose proper line of treatment.  
           Thiruvalluvar has stated this as, 
“§¿¡ö ¿¡Ê §¿¡ö Ó¾ø¿¡Ê «Ð ¾½¢ìÌõ 
Å¡ö ¿¡Ê Å¡öôÀî ¦ºÂø” 
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“¯üÈ¡ÉÇ×õ À¢½¢ÂÇ×õ ¸¡ÄÓõ 
¸üÈ¡ý ¸Õ¾¢î ¦ºÂø” 
      - ¾¢ÕìÌÈû 
So it is essential to know the disease, its etiology, the nature of the patient, 
severity of the illness, duration of disease , seasons and time of occurrence, etc., 
The management of the disease in Siddha is as follows, 
1. Neekkam(treatment) 
2. Niraivu(restoration) 
3. Kaappu(prevention) 
After occurrence of the disease, first it should be treated, restoration should be 
done and recurrence or further complications should be prevented.  
1. NEEKKAM: 
Nekkam is based on,  
· Balancing deranged thodams  to normal equilibrium state. 
· Treating with internal medicine and external medicine. 
· Deranged vaatham has to be brought to its normal state by giving purgation. It is 
mentioned in the following verses, 
“Å¢§ÃºÉò¾¡ø Å¡¾õ ¾¡Øõ” 
       -º¢ò¾ ÁÕòÐÅ¡í¸ ÍÕì¸õ 
 
Purgation: 
Agasthiyar kuzhambu – 130mg given with zinger juice , in early morning (for the 
first day only) 
Internal drug:  PARANGIPATTAI  RASAYANAM   
DOSAGE                                     :  Pakkalavu -6 gms   , twice a day 
ADJUVANT                                : MILK 
COURSE                                     : 24 DAYS 
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External drug: LASUNATHY  THYLAM       
DOSAGE:  Sufficient quantity (50 ml apply)  
 
2. NIRAIVU: 
The patient is convinced to accept the eventuality of the disease and modification 
of life style. 
                  “´ýÈ¢Â Å¡¾À¢ò¾ ¸ÀÁ¢¨Å ÔÂÃ¡ Åñ½õ 
¿ýÚÚ ¸È¢¸¦ÇøÄ¡õ ¿¡Ù§Á º¨ÁôÀ¡Ã¡öó§¾¡÷ 
¾¢ýÈ¢Î Á¢ÇÌ Áïºû º£Ã¸ ÓÂ÷ó¾ ¸¡Âõ 
¦ÅýÈ¢ ¦¸¡û Íì§¸¡§¼Äõ ¦Åó¾Âõ ¯ûÇ¢ §º÷ò§¾” 
- À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢ 
 To maintain normal level of three humours, pepper, turmeric, cuminseeds, 
asafoetida, dry ginger, cardamom, fenugreek and garlic should be added generously in 
diet. 
 
DIETARY ADVICE  
· ¸¡ö¸û 
                     ¸ò¾Ã¢À¢ïÍ,ÓÕí¨¸À¢ïÍ,,«Å¨ÃÀ¢ïÍ,À¢Ãñ¨¼ 
Ð¨ÅÂø  ¬¸¢Â¨Å §º÷ì¸ §ÅñÎõ. 
· ¸£¨Ã¸û: 
                    ¦À¡ýÉ¡í¸ñ½¢,ãì¸¢Ãð¨¼,àÐ§Å¨Ç, 
                    ÓÕí¨¸¸£¨Ã,¸È¢§ÅôÀ¢¨Ä, Ó¼ì¸Úò¾¡ý, 
                    «Ú¸£¨Ã, ¸Ã¢º¡¨Ä ¬¸¢Â¨Å §º÷ì¸ §ÅñÎõ. 
· ÀÆí¸û:  
                    Á¡Ð¨Ç,¬ôÀ¢û, ÀôÀ¡Ç¢, ¬ÃïÍ, §ÀÃ£î¨º, «ò¾¢, 
                             ¿¡Åø ,¬¸¢Â¨Å §º÷ì¸ §ÅñÎõ. 
· «¨ºÅõ: 
                    ¦ÅûÇ¡ðÎì¸È¢, ¸¡¨¼, º¢Ú þÈ¡ø Á£ ý  ¸ò¾¢Ã¢ì¸¡ö,  
                      «Å¨Ãì¸¡ö, Ó¾Ä¢Â ¦À¡Ã¢Âø¸§Ç¡Î ÜðÊ ¾ÃÄ¡õ. 
                    ÐÅÃõ ÀÕôÒ Ãºõ §º÷ì¸ §ÅñÎõ. 
 
          ·  ®ÃÁ¢øÄ¡ ¾¨ÃÂ¢Öõ, ÀÎì¨¸Â¢Öõ ÀÎò¾ø §ÅñÎõ, 
 ·  ÌÇ¢÷ ¸¡üÚ ÀÎõÀÊÂ¡É þ ¼ò¾¢ø þÕôÀ¨¾ ¾Å¢÷ì¸×õ 
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§º÷ì¸ Ü¼¡¾¨Å¸û:   
                                         
·  Í¨Ã                             ¯ôÒ   
·  âº½¢                            ÒÇ¢ôÒ     
· ¦ÅûÇÃ¢ì¸¡ö                «¾¢¸ ¨¸ôÒ     
· Ò¼¨Ä                           «¾¢¸ ¸¡÷ôÒ     
· À£÷ìÌ                            Áó¾ô ¦À¡Õû   
·  ¦Á¡î¨º                       ¦ÅüÈ¢¨Ä,À¡ìÌ       
· ¸¡Ã¡Á½¢                       Ò¨¸Â¢¨Ä          
· ¯ÙóÐ                          ÁÐ «ÕóÐ¾ø 
                ·  ¦¸¡ûÙ,                       ¦Àñ§À¡¸õ 
·  ¸ÎÌ                             
 
3. KAAPPU: 
Siddha system prominently projects prevention of diseases. This is attained by the 
following methods, 
1. Maintaining equilibrium of three humors by adopting vaanthi, kazhichal, 
nasiyam, nei muzhukku techniques. 
2. Avoiding stress and strain. 
3. Maintaining good mental health by doing meditation. 
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PERIARTHRITIS 
 
ANATOMY OF SHOULDER JOINT 
 
Syn: Glenohumeral joint  
 
The glenohumeral joint is a synovial ball and socket articulation between the 
head of the humerus and the glenoid cavity of the scapula . It is multiaxial with a wide 
range of movements provided at the cost of skeletal stability. Joint stability is provided, 
instead, by the rotator cuff muscles, the long head of the biceps brachii muscle, related 
bony processes, and extracapsular ligaments. Movements at the joint include flexion, 
extension, abduction, adduction, medial rotation, lateral rotation, and circumduction. 
 
The articular surfaces of the glenohumeral joint are the large spherical head of the 
humerus and the small glenoid cavity of the scapula . Each of the surfaces is covered by 
hyaline cartilage.  
 
Shoulder joint 
 
                                      
The glenoid cavity is deepened and expanded peripherally by a fibrocartilaginous 
collar (the glenoid labrum), which attaches to the margin of the fossa. Superiorly, this 
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labrum is continuous with the tendon of the long head of the biceps brachii muscle, which 
attaches to the supraglenoid tubercle and passes through the articular cavity superior to 
the head of the humerus. 
The synovial membrane attaches to the margins of the articular surfaces and lines 
the fibrous membrane of the joint capsule . The synovial membrane is loose inferiorly. 
This redundant region of synovial membrane and related fibrous membrane 
accommodates abduction of the arm. 
The synovial membrane protrudes through apertures in the fibrous membrane to 
form bursae, which lie between the tendons of surrounding muscles and the fibrous 
membrane. The most consistent of these is the subtendinous bursa of subscapularis, 
which lies between the subscapularis muscle and the fibrous membrane. The synovial 
membrane also folds around the tendon of the long head of the biceps brachii muscle in 
the joint and extends along the tendon as it passes into the intertubercular sulcus. All 
these synovial structures reduce friction between the tendons and adjacent joint capsule 
and bone.  
 
In addition to bursae that communicate with the articular cavity through apertures 
in the fibrous membrane, other bursae are associated with the joint but are not connected 
to it. 
These occur:  
· between the deltoid and supraspinatus muscle and the joint capsule (the 
subacromial bursa) 
· between the acromion and skin 
· between the coracoid process and the joint capsule;  
· in relationship to tendons of muscles around the joint (coracobrachialis, teres 
major, long head of triceps brachii, and latissimus dorsi muscles).   
The fibrous membrane of the joint capsule attaches to the margin of the glenoid 
cavity, outside the attachment of the glenoid labrum and the long head of the biceps 
brachii muscle, and to the anatomical neck of the humerus 
On the humerus, the medial attachment occurs more inferiorly than the neck and 
extends onto the shaft. In this region, the fibrous membrane is also loose or folded in the 
17 
 
anatomical position. This redundant area of the fibrous membrane accommodates 
abduction of the arm. 
Openings in the fibrous membrane provide continuity of the articular cavity with 
bursae that occur between the joint capsule and surrounding muscles and around the 
tendon of the long head of the biceps brachii muscle in the intertubercular sulcus. 
The fibrous membrane of the joint capsule is thickened:  
· anterosuperiorly in three locations to form superior, middle, and inferior 
glenohumeral ligaments, which pass between the superomedial margin of the 
glenoid cavity to the lesser tubercle and inferiorly related anatomical neck of the 
humerus  
· superiorly between the base of the coracoid process and the greater tubercle of the 
humerus (the coracohumeral ligament);  
· between the greater and lesser tubercles of the humerus (transverse humeral 
ligament)-this holds the tendon of the long head of the biceps brachii muscle in 
the intertubercular sulcus 
Joint stability is provided by surrounding muscle tendons and a skeletal arch 
formed superiorly by the coracoid process and acromion and the coraco-acromial 
ligament. 
Tendons of the rotator cuff muscles (the supraspinatus, infraspinatus, teres minor, 
and subscapularis muscles) blend with the joint capsule and form a musculotendinous 
collar that surrounds the posterior, superior, and anterior aspects of the glenohumeral 
joint. This cuff of muscles stabilizes and holds the head of the humerus in the glenoid 
cavity of the scapula without compromising the arm's flexibility and range of motion. The 
tendon of the long head of the biceps brachii muscle passes superiorly through the joint 
and restricts upward movement of the humeral head on the glenoid cavity. 
Vascular supply to the glenohumeral joint is predominantly through branches of 
the anterior and posterior circumflex humeral and suprascapular arteries. 
The glenohumeral joint is innervated by branches from the posterior cord of the 
brachial plexus, and from the suprascapular, axillary, and lateral pectoral nerves. 
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PERIARTHRITIS 
 
Synonyms 
 Frozen shoulder 
 Adhesive capsulitis 
 
Background: 
Adhesive capsulitis and frozen shoulder syndrome (FSS) are 2 terms that have 
been used to describe an array of clinical conditions, including subacromial bursitis, 
calcifying tendinitis, and partial rotator cuff tears. Despite the diverse nomenclature used 
to describe FSS, all of these terms denote different clinical conditions that may cause the 
painful restriction of active and passive glenohumeral and periscapular shoulder motion.  
Lundberg divided patients who met the pain and motion requirements of frozen 
shoulder into 2 groups: primary and secondary.A patient meets the criteria of primary or 
secondary FSS if painful, restricted active and passive glenohumeral and scapulothoracic 
motion occurs for at least 1-month duration and has either reached a plateau or worsened. 
This inclusion period for defining frozen shoulder is similar to that described by Binder 
and colleagues  but is shorter than that defined by Lloyd-Roberts and coworkers. 
Patients with primary frozen shoulder have no significant findings in the history, 
clinical examination, or radiographic evaluation to explain their motion loss and pain. 
Classically, symptoms of primary frozen shoulder have been divided into 3 phases: (1) 
the painful phase, (2) the stiffening phase, and (3) the thawing phase. In the initial painful 
phase, there is a gradual onset of diffuse shoulder pain lasting from weeks to months. The 
stiffening phase is characterized by a progressive loss of motion that may last up to 1 
year. Most patients lose glenohumeral external rotation, internal rotation, and abduction 
during this phase. The final, thawing phase is measured in weeks to months and 
constitutes a period of gradual motion improvement. Once in this phase, the patient may 
require up to 9 months to regain a functional range of motion (ROM). 
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In contrast to patients with primary FSS, patients with secondary FSS describe an 
event that preceded shoulder symptomatology, such as trauma or surgery to the affected 
upper extremity. 
 
Definition of Frozen Shoulder: 
The term frozen shoulder (FS) is used to describe a clinical condition with 
restricted active and passive range of motion in all directions, flexion, abduction and 
rotation. 
 
The definition, also defined by Lundberg, is: 
- shoulder joint elevation of ≤135° 
- restriction of motion is localised to the glenohumeral joint 
  
It is defined as a clinical syndrome characterised by painful restriction of both 
active and passive shoulder movements due to causes within the shoulder joint or remote 
(other parts of the body) 
Epidemiology 
Frequency 
Frozen shoulder usually affects patients aged 40-70 years. Incidence of FSS is not 
precisely known; however, it is estimated that 3% of people develop the disease over their 
lifetime. Males tend to be affected less frequently than females, and there is no 
predilection for race.  
frozen shoulder has been associated with several conditions. A higher incidence of 
frozen shoulder exists among patients with diabetes (10-20%) compared with the general 
population (2-5%). Incidence among patients with insulin-dependent diabetes is even 
higher (36%), with an increased frequency of bilateral shoulder involvement 
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Etiology: 
· The precise cause of Frozen Shoulder is unknown. 
· It can occur after a single traumatic injury to the shoulder, especially in the 
area of the joint capsule; overuse injuries or repetitive stress such as in 
competitive sports; prolonged immobilization of the shoulder as in the case 
of a fracture.  
· Women and people over 40 are more likely to develop this condition.  
· People with diabetes have a higher risk of developing this problem than 
the general population.  
· The same is true for people with chronic fatigue syndrome, 
· people with history of heart disease or strokes, or cervical diseases, 
· people with hypo- or hyperthyroidism. 
· In view of these statistical relationships, frozen shoulder has been 
considered by researchers to have an autoimmune component, meaning 
that the body's immune system may attack the healthy parts of the body, in 
this case the capsule and connective tissue of the shoulder. 
 
Types:  
· Perhaps it is wise to use the initial classification of Lundberg (1969): 
- Primary Frozen shoulder 
- Secondary Frozen shoulder 
· But not even this is clear – these groups need to be subdivided: 
- Primary Frozen shoulder  
Diabetic 
- Secondary Frozen shoulder  
 
Post-traumatic 
Latrogenic 
Other 
· In some, the diabetic frozen shoulder is a Secondary type .The secondary may be 
divided into 
·  Extrinsic (causes outside the joint) and 
· Intrinsic (causes inside the joint). 
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Intrinsic (Shoulder causes): problems directly related to shoulder joint which can give 
rise to frozen shoulder are tendinitis of rotator cuff, bicipital tendinitis, fractures and 
dislocations around the shoulder, etc. 
Extrinsic (Nonshoulder causes): problems not related to shoulder joint like diabetes, 
cardiovascular diseases with referred pain to the shoulder which keeps the joint immobile, 
reflex sympathetic dystrophy, frozen hand shoulder syndrome, a complication of Colles’ 
fracture can all lead to frozen shoulder. The reason could be prolonged immobilisation of 
the shoulder joint due to referred pain, etc. 
 
PATHOGENESIS: 
 
When looking at secondary frozen shoulder, the cause of the syndrome is usually 
easy to define.  
In the post traumatic cases there is clear evidence of a trauma and usually also 
structural changes within or adjacent to the joint, such as fractures, chondral lesions, 
avascular necrosis or tendon injuries. Scarring following traumatic tissue injury is another 
cause. 
The iatrogenic cases occur following treatment, usually surgery. In these cases 
extreme scarring following tissue repair may occur or surgical mistakes such as over 
tightening of soft tissue may be responsible for the following limitation in range of 
movement. 
 
Clinical features: 
  There are three classical stages in frozen shoulder. 
Stage I (Stage of pain): patient complains of acute pain, decreased movements, external 
rotation greatest followed by loss of abduction and then forward flexion. Internal rotation 
is least affected. This stage lasts for 10 to 36 weeks. 
Stage II (Stage of Stiffness): in this stage pain gradually decreases and the patient 
complaints of stiff shoulder. Slight movements are present. 
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Stage III (Stage of Recovery): patient will have no pain and movement will have 
recovered but will never be regained to normal. It lasts for 6 months to 2 years. 
Signs and Symptoms of Periarthritis 
· The shoulder joint becomes painful and stiff 
· The cause for this inflammatory disease is not known 
· There occurs a loss of resilience of the joint capsule, possibly due to adhesion 
formation 
· In the early stages of the disease, the pain is worse at night and the movements are 
slightly restricted 
· Later, there is pain at all times and all the shoulder movements get severely limited 
· There could possibly be a history of trauma 
Tests and diagnosis 
· Hands up. Raise both your hands straight up in the air, like a football referee calling a 
touchdown. 
· Opposite shoulder. Reach across the chest to touch the opposite shoulder. 
· Back scratch. Starting with the back of the hand against the small of the back, reach 
upward to touch the opposite shoulder blade. 
Diagnosis: 
 Frozen shoulder can usually be diagnosed from signs and symptoms and X-rays 
or an MRI — to rule out other structural problems 
If a physical exam reveals limited shoulder movement. An X-ray may be done to 
see whether symptoms are from another condition such as arthritis or a broken bone. 
  An arthrogram, which is an X-ray image of joint taken after a contrast material 
(such as a dye or air) is injected into it, can help confirm the diagnosis 
Clinical Examination of Frozen shoulder: 
History 
- age: 45+ (insidious type) 
- Insidious onset or after trauma or surgery 
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- Functional restriction of LR, ABD, MR (capsular pattern) 
- Normal bone and soft tissue outlines 
Observation 
- Normal bone and soft tissue outlines 
AROM  (Active Range Of Motion) 
- restricted ROM 
- shoulder hiking 
PROM  (Passive Range Of Motion) 
- Limited ROM, especially in: LR, ABD, MR (capsular pattern) 
RROM 
- Normal, when arm by side 
Sensory function and reflexes 
- not affected 
Palpation 
- Not painful unless, capsule is stretched 
Diagnostic imaging 
- Radiography: negative  
- Arthrography: decreased capsular size 
Lifestyle and home remedies 
Continue to use the involved shoulder and extremity in as many daily life 
activities as possible within the limits of your pain and range-of-motion constraints. 
Applying heat or cold to your shoulder can help relieve pain. 
One of the most common causes of frozen shoulder is the immobility that may 
result during recovery from a shoulder injury, broken arm or a stroke. If you've had an 
injury that makes it difficult to move your shoulder 
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1. Differential diagnosis: 
 1. Rotator Cuff 
History 
- age : 30 - 50 yrs 
- Pain and weakness after eccentric load 
Observation 
- Normal bone and soft tissue outlines 
- protective shoulder hike may be seen 
AROM 
- weakness of abduction or rotation or both 
- crepitus may be present 
PROM 
- Pain if impingement occurs 
RROM 
- Pain and weakness on abduction and lateral rotation 
Special tests 
- Drop arm test is positive 
- Empty can test is positive 
Sensory function and reflexes 
- not affected 
Palpation 
- tender over rotator cuff 
Diagnostic imaging 
- Radiography: upward displacement of humeral head; 
- acromial spurring 
- MRI diagnostic 
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2. A traumatic instability 
History 
- age: 10 - 35 yrs 
- Pain and instability with activity 
- no history or trauma 
Observation 
- Normal bone and soft tissue outlines 
AROM 
- full or excessive ROM 
PROM 
- Normal or excessive ROM 
RROM 
- Norm 
Special tests : 
- Load and shift test is positive 
- Apprehension test is positive 
- Relocation test is positive  
-Augmentation test is positive 
Sensory function and reflexes -  anterior or posterior pain 
Palpation - negative 
3. Cervical Spondylosis 
History 
- age 50+ yrs 
- Acute or chronic 
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Observation 
- Minimal or no cervical spine movement 
- Torticollis may be present 
AROM 
- limited ROM with painPROM 
- Limited ROM (Symptoms may be exacerbated) 
RROM 
- Normal, except if nerve root compressed 
- Myotome may be affected 
Special tests : 
- Spurling's test is positive 
- Distraction test is positive 
- ULTT is positive 
- Shoulder abduction test is positive (put your hand on top of your head) 
Sensory function and reflexes 
- Dermatomes affected 
- Reflexes affected 
Palpation 
- tender over appropriate vertebra or facet 
Diagnostic imaging 
- Radiography: narrowing osteophytes 
Management: 
Treatment goals include reduction in pain and inflammation, as well as preserving 
mobility and preventing disability and recurrence. The treatment recommendations may 
include a combination of rest, splints, heat and cold application.  
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PROPERTIES OF TRIAL DRUG 
1. PARANGIPATTAI  RASAYANAM (INTERNAL)   
INGREDIENTS 
Parangipattai – Smilax china .Linn – 16 balam (560 grms) 
Kodiveli - Plumbago zeylanica   
Sanguver – Clitoria ternatea ,linn. 
Amukaraa – Withania somnifera (linn) dunal 
Nilappanai – Curculigo orchiodes .gaertn 
Thipilimoolam - Root of Piper longum, Linn. 
Thalisapathiri - – Abies spectabilis (d.don) mirb 
Lavangapathiri –Cinnamomum tamala (buch,hum) nees. 
Milagu - Piper nigrum,Linn. 
Thipili - Piper longum,Linn. 
Omam – Carum capticum benth andhook.f. 
Kurosaaniomam – Hyoscyamus niger Linn 
Kaurunjeeragam – Nigella sativa,Linn. 
Sitharathai - Alpinia officinarum (Linn) wild 
Perarathai -  Alpinia galanga (Linn) wild 
Kadukkai - Terminalia chebula, Retz 
Thaanrikai - Terminalia bellarica.(Gaertn) Roxb 
Nellimulli - Phyllanthus emblica,Linn 
Sevviyam - Root of Piper nigrum, Linn. 
Vaalmilagu – Piper cubeba .lin f 
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Kozhtam - Costus specius,(Koenig ex Retz) J.E.Smith 
Kasakasa – Papaver somniferum Linn. 
Malli – Coriandrum sativum ,Linn. 
Jadaamanjil – Nardostachys grandiflora ,dc. 
Kiraambu – Syzygium aromaticum (Linn)merrill and perry 
Saathikaai – Myristica fragrans houtt 
Lavangapattai – Cinnamomum verum , presl 
Sukku - Zingiber officinale, Rose. 
Above all the drug each - ½ balam (17.5 gms) 
Ghee    - 2 padi ( 4litre ) 
Sugar    - 2 saer (560 gms ) 
 Cow’s Milk   - sufficient amount 
Honey    - 1padi (2 litres) 
 
2.LASUNATHY THYLAM (EXTERNAL) 
INGREDIENTS:  
Vellulli – Allium sativum, linn.  - 1 padi (2litr) 
Arathai – Alpinia galanga (linn) wild - 1/2 palam (17.5gms) 
Vaaivilangam – Embelia ribes,F.Burm -  1/2 palam ( 17.5gms) 
Vasambu – Acorus calamus. Linn  - 1 /2palam ( 17.5gms) 
Sevviyam - Root of Piper nigrum, Linn. - 1 palam ( 35gms ) 
Manjal  - Curcuma longa,Linn.  - 1 palam ( 35gms ) 
Maramanjal - Coscinium fenestratum,(Gaertn)Colebr-1 palam ( 35gms ) 
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Milagu   -  Piper nigrum,Linn   -  3 palam ( 105gms ) 
Thipilimoolam -  Root of Piper longum, Linn.  -  3 palam ( 105gms ) 
Murungai  –   Root of Moringa oleifera lam. -  1/4 palam ( 8.75gms ) 
Nochi   –  Root of Vitex negundo,linn.  -  1/4 palam ( 8.75gms ) 
Kandankathiri –  Root of Solanum surattense,Burn.f. - 1/4 palam ( 8.75gms ) 
Mulli   –  Root of Hygrophila auriculata  -  1/4 palam ( 8.75gms ) 
Erukkampoo  –  Root of Calotropis gigantea (linn )R.Br - 1/4 palam ( 8.75gms ) 
Aayilpattai  –  Root of Chukrasia tabularis,a.juss  - 1/4 palam ( 8.75gms ) 
Kodiveli  –  Root of Plumbago Zeylanica  .linn  - 1/4 palam ( 8.75gms ) 
Gingelly oil -   4 padi (8 litr ) 
 
rq;fd; 
Botanical Name    : Azima tetracantha,lam 
Parts used             : Root, Leaves  
Organoleptic Characters 
Taste   -  Kaippu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
tPf;fk ; fug;ghd; tpjhfk; fpue;jpFd;kk; 
Cf;fkpF #iytha; NthLgpj;je; - jhf;Ftplk; 
tPWNkh fz;Jyq;Fk; tPRgrp uj;jKz;lhk; 
$Wrq;fk; Nthpiy fl;F. 
-அக திய   ணவாகட  
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Therapeautic Actions 
 Diuretic 
 Stimulant 
Astringent 
Tonic 
 Antiperiodic 
 Expectorant 
 
mKf;fhuh 
Botanical Name    :  Withania somnifera, linn 
Parts used             : Tubers, Leaves, Seed 
Organoleptic Charecters 
Taste   -  Kaippu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
nfhQ;re; Jth;g;ghq; nfhbafak; #iyahp 
kpQ;Rfug; ghd;ghz;L ntg;gjg;G – tpQ;rp 
KRTW NjhlKk;Ngh Nkhfk;md Yz;lhk; 
mRtfe; jpf;nfd; wwp. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Soporific 
 Sedative 
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Aphrodisiac 
 Deobstruent 
 Diuretic 
 Tonic 
 
epyg;gid 
Botanical Name    : Curculigo orchioides.Gaertn 
Parts used             : Tubers, Root 
Organoleptic Charecters 
Taste   -  Inippu 
Potency       - Thatpam 
 Pirivu          - Inippu 
 
¦À¡Ð Ì½õ 
Nkf tdy;jzpAk; ntz;Fl;le; jhd;tpyFk; 
Nghf kpfTKWk; nghw;nfhbNa! – Nghfhj 
#iyNk fq;fNshL Jd;DfUk; Gs;spAk;NghQ; 
rhy epyg;gidf;Fj; jhd; 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Tonic 
 Diuretic 
Astringent 
Carminative 
Emollient 
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jhsprgj;jphp 
Botanical Name    : Abies spectabilis ,Mirb 
Parts used             : Leaf 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
ehrp fsg;gpzpfs; ehl;gl;l - fhrQ;R 
thrk; mUrp tdkq;fhy; - tPrptU  
Nkfke;jk; mj;jpRuk; tpl;NlFe; jhsp;rj;jhy; 
MFQ; Rfg;gpur tk; 
-அக திய   ணவாகட  
Therapeautic Actions 
 Stomachic 
 Carminative 
 Expectorant 
 Tonic 
 
,ytq;fg;gj;jphp 
Botanical Name    : Cinnamomum tamala Nees. 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
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¦À¡Ð Ì½õ 
NkfRuk; rPjRuk; ntl;ilRth rq;fhrk; 
jhfgpj;jk; the;jprh; thrpaNeha; - Nkfj;jpd; 
fl;bnahL jhJel;lq; ifg;gUrp Nghf;fptpLk; 
,l;l,y tq;fj; jpiy 
-அக திய   ணவாகட  
Therapeautic Actions 
Stomachic 
 Carminative 
 Stimulant 
 Diaphoretic 
 
Xkk; 
Botanical Name    : Carum copticum benthandhook.f. 
Parts used             : Seeds 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
rPjRuq; fhrQ; nrhpahke; jk;nghUky; 
Ngjpapiur; ry;fLg;G Nguhkk; - XjpUky;  
gy;nyhLgy; %yk; gfkpitNeh nad;nrANkh? 
nrhy;nyhLNghk; Xknkdr; nrhy; 
-அக திய   ணவாகட  
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Therapeautic Actions 
Antiseptic 
Stomachic 
 Carminative 
 Antispasmodic 
Stimulant 
 Tonic 
 Sialogogue 
 
FNuhrhzp Xkk; 
Botanical Name    : Hyoscyamus niger linn. 
Parts used             : Seeds 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
ntF%j; jpuk;thjk; tPhpael; lk;Gz; 
cFNgjp Al;fLg;gp NdhNl – kpFfug;ghd; 
jPuhf; fgkpitNghk; nra;aF Nuhrhdpnad;why; 
thuh kaf;fKW khy; 
-அக திய   ணவாகட  
 
 
 
35 
 
Therapeautic Actions 
 Hypnotic 
Sedative 
Anodyne 
Antispasmodic 
Mild Diuretic 
 
rpw;wuj;ij 
 
Botanical Name    : Alpinia officinarum (Linn) wild 
Parts used              : Root 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
thjgpj; jq;fug;ghd; thjQ; rpNuhNuhfQ; 
Nrh;e;jfg Kj;NjhlQ; rPjnkhL – Neh;e;jRuk; 
kw;wuj;ijf; fhl;b tUkpUk Ye;jPUk; 
rpw;wuj;ij td;kUe;jhy; Njh;. 
-ேதர    ணவாகட  
Therapeautic Actions 
 Expectorant 
 Febrifuge 
 Stomachic  
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Nguuj;ij 
Botanical Name   : Alpinia galanga (Linn) wild 
Parts used             : root 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
muj;ij fgj;ij mWf;Fq;fhy; Xl;LQ; 
rpuj;jpYWk; <isiar; rpijf;Fk; - ,iuj;JtUk; 
gpj;jNjh lj;ijg; gpwtypg;ig khw;wptpLk; 
cw;wrh;t ty;ptplk;Nghf; Fk;. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Expectorant 
 Febrifuge 
 Stomachic 
 
ney;yp 
Botanical Name    : Phyllanthus emblica,Linn 
Parts used             : Fruits, Leaves, Flowers, Root, Seed 
Organoleptic Charecters 
Taste   -  Pulippu, Thuvarppu, Inippu 
Potency       - Thatpam 
 Pirivu          - Inippu 
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¦À¡Ð Ì½õ 
gpj;jkd iyak; gPerk;tha; ePh; the;jp 
kj;jkyf; fhLk; kaf;fKkpy; - xj;jTU 
tpy;ypf;fh ak;kUq;fh nkd;dhl;fh ye;Njh;e;Nj 
ney;ypfh ak;kUe; JzP. 
- ேதர   ணவாகட  
 
Therapeautic Actions for Fruits 
 Refrigerant 
 Diuretic 
Laxative 
nrt;tpak; 
 
Botanical Name   : Root of Piper nigrum, Linn. 
Parts used            : Root 
¦À¡Ð Ì½õ 
#iy mUfprd;dp njhy;ypUky; <isgpj;jk; 
Nkiyf; Fuw;fk;ky; ntq;fsNeha; - %yRuk; 
ft;tpaq;fj; NjW fdjh tutplKQ; 
nrt;tpaq; nfhs;stpLe; Njh;. 
-அக திய   ணவாகட  
 
thy;kpsF 
Botanical Name    : Piper cubeba .linn 
Parts used             : Dried Unriped fruit 
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Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
thjgpj;j Iak; tapw;W typjhfQ; 
rPjk; gyNeha; rpijAq;fhz; - Nghj 
mjpjP gdkhk; mzq;fuNr! ehSe; 
Jjpthy; kpsfUe;jr; nrhy;. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Stimulant 
 Carminative 
 Diuretic 
 Expectorant 
 
Nfhl;lk; 
Botanical Name    :  Costus speciorus, (Koenig ex Retz) J.E.Smith 
Parts used             : Root 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
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¦À¡Ð Ì½õ 
ehl;bYU ntl;il eLf;fk; vDNeha;fs; 
Nfhl;lnkdr; nrhd;dhy; FiyAq;fhz; - $l;bw; 
RuNjhle; njhz;ilNeha; Njhyhj gpj;jk; 
guNjrk; NghNk gwe;J. 
-அக திய   ணவாகட  
Therapeautic Actions 
 Stomachic 
 Expectorant 
 Tonic 
 Stimulant 
 Diaphoretic 
 
frfrh 
Botanical Name    : Papaver somniferum Linn 
Parts used             : Seed 
Organoleptic Charecters 
Taste   -  Inippu 
Potency       - Veppam 
 Pirivu          - Inippu 
 
¦À¡Ð Ì½õ  
fpUkp eikr;ry; fpuhzpajp rhuQ; 
rpuePh; mepj;jpiuNghQ; nrg;gpy; - cUtoFq; 
fhe;jpAKz; lhFq; frfrh tpd;Fzj;ijj; 
Njh;e;jth;f;F tpe;JTkhe; Njh; 
-அக திய   ணவாகட  
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Therapeautic Actions 
 Demulent 
 Nutritive 
 Mild Astringent 
 
nfhj;Jky;yp 
 
Botanical Name    : Coriandrum sativum ,Linn. 
Parts used             : Seed, Leaves 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Seetha Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
nfhj;Jky;yp ntg;gk; Fsph;fha;r;ry; gpj;jke;jQ; 
rh;j;jptpf;fy; jhfnkhL jhJel;lk; - fj;jpnaOk; 
thj tpfhh;klh; td;fh;j;j gptpuzk; 
G+jyj;jpy; yhjfw;Wk; Nghw;W. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Stomachic 
 Carminative 
Stimulant 
Diuretic 
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rlhkhQ;rp 
 
Botanical Name    :  Nardostachys grandiflora ,De. 
Parts used             : Root 
Organoleptic Charecters 
Taste   -  Inippu (Green) / Kaarppu (Dried) 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
Fl;lQ; rpye;jptplk; Nfhu Guhz Ruk; 
cl;bdq;fhy; Ngjpfz;Nzha; xl;bUky; - nrhl;buj;j 
gpj;jkpiug; NgFk; ngUq;Nfhiu vd;Wiuf;FQ; 
Rj;jrlh khQ;rpiy nrhy;. 
-அக திய   ணவாகட  
Therapeautic Actions 
 Stimulant 
Diuretic 
Expectorant 
Antispasmodic 
 
,ytq;fk; 
 
Botanical Name    : Syzygium aromaticum linn, 
Parts used             : bud 
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Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
gpj;j kaf;fk;; NgjpnahL the;jpAk;Nghk; 
Rj;jtpuj; jf;fLg;Ge; Njhd;WNkh – nkj;j 
,ytq;fq; nfhz;ltUf; Nfw; RfkhFk; 
kykq;Nf fl;Lnkd tho;j;J. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Carminative 
Stomachic 
Antispasmodic 
 
rhjpf;fha; 
Botanical Name    :  Myristica fragrans, houtt 
Parts used             : Fruit 
Organoleptic Charecters 
Taste   -  Thuvarppu, Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
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¦À¡Ð Ì½õ 
jhJ el;lk; Ngjp rUthrp aQ;rpu Neha; 
XJRth rq;fhrk; cl;fpuzp – NtNjh 
byf;fha; tUk;gpzpNghk; Vw;wkay; gpj;jq; 
Fyf;fh aUe;Jth;f;Ff; $W.  
- அக திய   ணவாகட  
Therapeautic Actions 
 Stimulant 
 Carminative 
Aromatic 
Narcotic 
Tonic 
,ytq;fg;gl;il 
Botanical Name    : Cinnamomum verum,presl 
Parts used             : bark 
Organoleptic Charecters 
Taste   -  Kaarppu, Inippu 
Potency       - Thatpam 
 Pirivu          - Inippu 
 
¦À¡Ð Ì½õ 
jhJel;lk; Ngjp rUttp\k; MfpaNeha; 
G+jfpu fQ;rpye;jpg; G+r;rptplQ; - rhjptplk; 
Ml;Lkpiug; NghbUky; MfpaNeha;f; $l;lkw 
Xl;Lkpy tq;fj; Jhp. 
-அக திய   ணவாகட  
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Therapeautic Actions 
Stimulant 
 Carminative 
 Aphrodisiac 
 
fUk;G 
Botanical Name    : Saccharum officinarum.linn 
Parts used             : Cane Juice, Jaggery, Root 
Organoleptic Charecters 
Taste   -  Inippu 
Potency       - Seetham 
 Pirivu          - Inippu 
 
¦À¡Ð Ì½õ 
fUk;gpuj nkj;jTz;lhw; fhZq; fgNeha; 
tpUk;gpnty;y nkj;jTz;lhy; Nkfk; - jUkJePh; 
cz;lh kijkpjkh Az;lhy;Nk fk;gpj;jk; 
kpz;lhkw; rhe;jKWk; tp;s;. 
-அக திய   ணவாகட  
 
Therapeautic Actions for Jaggery 
 Antiseptic 
 Demulcent 
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kukQ;rs; 
Botanical Name    : Coscinium fenestratum,(Gaertn)Colebr 
Parts used             : Tuber 
Organoleptic Charecters 
Taste   -  Kaippu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
mod;wfz %yk; mUrp AlNd 
cod;w fzr;RuKk; XLQ; - Rod;Ws;Ns 
tPWRu Ke;jzpAk; tPRku kQ;rSf;Fj; 
NjW nkhopadNk! nrg;G. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Febrifuge 
Stomachic 
Tonic 
 
nehr;rpNth; 
Botanical Name    : Vitex negundo,linn. 
Parts used             : Root 
Organoleptic Charecters 
Taste   -  Kaippu, Thuvarpu, Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
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¦À¡Ð Ì½õ 
Nehah fypia nehbf;F sUe;jntk;ik 
Nahah kzhS Kah;j;JjYf; - fha 
te;jKjy; ez;ghfp thjj;ij NaAwthw; 
rpe;Jth uq;fYe; jP 
-ேதர  ெவ பா 
Therapeautic Actions for Root 
 Febrifuge 
Expectorant 
Diuretic 
 
fz;lq;fj;jphpNth; 
 
Botanical Name    : Solanum surattense,Burm.f. 
Parts used             : Root 
Organoleptic Charecters 
Taste   -  Kaarppu 
Potency       - Veppam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
fhr Rthrq; fjpj;j\a ke;jkdy; 
tPRRuQ; rd;dp tpisNjhlk; - MRWq;fhy; 
,j;jiuA zpw;fh vhpfhuQ; Nrh;f;fz;lq; 
fj;jphpAz; lhkhfpw; fhz;. 
-அக திய   ணவாகட  
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Therapeautic Actions 
Expectorant 
Diuretic 
Carminative 
 
KUq;ifNth; 
Botanical Name    : Moringa oleifera lam 
Parts used             : Root 
Organoleptic Charecters 
Taste   -  Kaippu, Thuvarppu, Inippu 
Potency       - Thatpam 
 Pirivu          - Kaarppu 
 
¦À¡Ð Ì½õ 
nrwpke;jk; ntg;ge; njwpf;Fe; jiyNeha; 
ntwp%h;r;ir fz;Nzha; tpyFk; - kwNk 
neUq;ifapiy nahj;jtpop NehpioNa! ey;y 
KUq;if apiyia nkhop. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Acrid 
 Vosiceant 
 Antilithic 
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ePh;Ks;spNth; 
 
Botanical Name    :  Hygrophila auriculata 
Parts used             : Root 
Organoleptic Charecters 
Taste   -  Inippu, Sirukaippu 
Potency       - Thatpam 
 Pirivu          - Inippu 
 
¦À¡Ð Ì½õ 
tpe;JTkhk; jhJTkhk; NkfNuhfe;njhiyAk; 
ce;J kjprhuk; xopAq;fhz; - te;Jlypy; 
VwpaePh; tPf;fk; ,wq;Fk; ,isg;GkWk; 
$wpaePh; Ks;sptpijf;F. 
-அக திய   ணவாகட  
 
Therapeautic Actions 
 Refrigerant 
 Diuretic 
 Demulcent 
 Tonic 
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¬Â¢ø Àð¨¼ 
Botanical name : Chukrasia tabularis 
¦À¡ÐìÌ½õ: 
“¬Â¢ÖÃ¢¨Â ÂÊ¿£Õ ½¢ò¾¢Â¦Áö 
Â¡Â¢ ÖÃ¢¨Â¦ÂÉ¢ Ä¡Å¢Á¢¨º Â¡Â¢ø 
ÅÃ¢¨ºÂ¡ì ¸üÌ¿¢¸÷ ÅøÄ¢ÂðÎñ ¦ÁöìÌ 
ÅÃ¢¨ºÂ¡ì ¸ò¨¾ÔÚ ¨Å.” 
- §¾¨ÃÂ÷ ÂÁ¸õ 
    Å¡¾¡¾¢ Óò§¾¡¼í¸¨ÇÔõ À¨ÆÂ ÍÃò¨¾Ôõ §À¡ìÌõ. 
 
 
 CHEMICAL CONSTITUENTS: 
  Haloptelin – A & B, friedelin, epifriedelinol, B – sitosterol, tannins,                
2 – aminonapthaquinone. 
       Database, Vol – II, P – 172 
ACTIONS: 
Febrifuge 
Counter –irritant 
Pharmacological activities: 
Anti – inflammatory, astringent, digestive. 
 Database, Vol – II, P – 171, 172 
Uses: 
They are used in inflammations, rheumatism.  
Database, Vol – II, P – 171 – 172 
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ÀÈí ôÀð¨¼  
Botanical Name : Smilax chinensis. Linn 
Family  : Liliaceae 
Organoleptic characters: 
· Suvai - Inippu 
· Thanmai - Thatppam 
· Pirivu –Iinippu 
 
¦À¡Ð Ì½õ 
¾¡¸õ ÀÄÅ¡¾ó ¾¡Ð¿ð¼õ ÒñÀ¢Ç¨Å 
§Á¸í ¸Ê¸¢Ãó¾¢ Å£úãÄó- §¾¸Ó¼ý 
Ìð¨¼ À¸ó¾§Áü ¦¸¡ûÅÁÉõ §À¡õÀÈí¸¢ô 
Àð¨¼Â¢¨É ÔîºÃ¢òÐô À¡÷. 
- ேதர   ணவாகட  
Action 
· Alterative 
· Antisyphilitic 
· Aphrodisac 
· Depurative 
 
Uses 
· Relives Thirst, 
· Vaatha diseases, 
· Skin diseases, 
· Veneral diseases, 
· Haemorrhoids, 
· Vomiting. 
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¦¸¡Ê§ÅÄ¢ 
 
Botanical Name : Plumbago indica. Linn 
Family  : Plumbaginaceae 
Organoleptic Characters 
 
· Suvai - Kaarppu 
· Thanmai - Veppam 
· Pirivu – Kaarppu 
 
¦À¡Ð Ì½õ 
¸ðÊÅ¢Ã ½í¸¢Ãó¾¢ ¸¡ø¸û «¨ÃÂ¡ôÒì 
¸ðÊîÝ ¨ÄÅ£ì¸í ¸¡úãÄõ -ÓðÊÃò¾ì 
¸ðÎ¿£ §ÃüÈí ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
«ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ. 
- அக திய   ணவாகட  
Actions 
 
· Anti-periodic 
· Diaphoretic 
 
Uses 
· Abscess, 
· Ulcers, 
· Vaathadisease, 
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· Dropsy, 
· Pricking pain, 
· Haemorrhoid, 
· Sinusitis, 
· Ascites, 
· Contusion. 
 
¾¢ôÀ¢Ä¢ ãÄõ 
Botanical name : Piper longum 
Family  : Zingeberaceae 
Parts used  : Root 
ORGANOLEPTIC CHARACTERS 
Taste  : Kaarppu 
Potency : Veppam 
Division : Kaarppu 
¦À¡Ð Ì½õ 
jhfgpj;jQ; Nrhfe; jzpahr; RukpUky; 
Nkfq; Fuw;fk;ky; nka;f;fLg;Gk; - VFq;fhz; 
jpg;gpyp% yq;fz;lj; jpg;gpypa jhk;eWf;Fj; 
jpg;gpypnad; NwnahUf;fhw; nrg;G. 
-அக திய  ணவாகட  
 
 
THERAPEUTIC ACTION: 
· Stomachic 
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USES: 
It is used in the treatment of thrist, pitha diseases, toxic fever, cough, sore throat, 
pricking body pain and veneral diseases. 
 
 
Á¢ÇÌ 
Botanical Name : Piper nigrum. Linn 
Family  : Piperaceae 
 
Organoleptic characters 
Taste : kaarppu 
Potency : veppam 
Pirivu : kaarppu 
 
¦À¡Ð Ì½õ 
"º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ-μÎºýÉ¢ 
Â¡ºÁÀŠ Á¡Ãõ «¼ý§Á¸õ ¸¡ºÁ¢¨Å 
¿¡ºí ¸È¢Á¢Ç¸¢É¡ø. 
 
§¸¡Ï¸¢ýÈ Àì¸ÅÄ¢ ÌöÂ×§Ã¡ ¸õÅ¡¾ 
§º¡½¢¾í¸ Øò¾¢üÌû §¾¡ýÚ§¿¡ö-¸¡½Ã¢Â 
¸¡Ð§¿¡ö Á¡¾÷ÌýÁí ¸¡Á¡¨Ä Áó¾¦ÁýÈ£÷ 
²Ð§¿¡ö ¸¡Â¢Õì¸¢ø ®íÌ." 
 
-ேதர   ணவாகட  
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Uses: 
It is useful in treating cold, cough, fever, gastric ulcer, haemorrhoids, vaatha 
diseases, etc. It is an effective antidote. 
 
Actions: 
· Acrid 
· Carminative 
· Antiperiodic 
· Rubifacient 
· Stimulant 
· Resolvent 
· Antivaatha 
· Antidote 
Phytochemicals: 
The principle ingredients of Piper nigrum are dimeric amide alkaloids with 
cyclohexene ring, nigramides, Piperine, piperidine,dimeric amide alkaloids with 
cyclobutane ring, nigramides P-S 
 
¸Õïº£Ã¸õ 
Botanical name      :  Nigella sativa.Linn 
Family                      :   Ranunculaceae 
Parts used             :   Seed 
 
Organoleptic Characters 
Taste     : Kaippu 
Potency : Veppam 
pirivu     : Kaarppu 
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¦À¡Ð Ì½õ 
              “¸Õïº£ Ã¸ò¾¡ý ¸ÃôÀ¦É¡Î ÀñÏõ 
                ÅÕïº¢Ã¡öô À£¿ºÓ Á¡üÚõ - «Õó¾¢É¡ø 
                ¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
      Å¡öîº ÁÕó¦¾É§Å ¨Å.”  
- அக திய  ணவாகட  
 
 Therapeautic action: 
· Carminative 
· Diuretic 
· Emmenagogue  
· Galactogogue  
· Anthelmintic  
· Stomachic  
· Parasiticide  
· Emollient  
 
   Uses: 
                It cures eczema, wounds, sinusitis, fever, headache and painful eye 
 
¸Îì¸¡ö 
Botanical Name : Terminalia chebula. Retz. 
Family  : Combretaceae 
Part used  : Dry fruit. 
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Organoleptic characters: 
· Taste : Astringent,little hot and spicy sweet, sour, bitter. 
· Potency : Hot 
· Pirivu : Sweet 
 
Phytochemicals: 
·   Chebulinic acid 
·   Gallic acid 
¦À¡Ð Ì½õ 
 
“¾¡¨¼ ¸Øò¾ì¸¢ ¾¡Ö ÌÈ¢Â¢Å¢¼ô 
À£¨¼ º¢Ä¢À¾Óü §À¾¢Ó¼õ - ¬¨¼¦Âð¼¡ò 
àÄÁ¢Ê ÒñÅ¡¾ §º¡½¢¸¡ Á¡¨ÄÂ¢Ãñ 
¼¡ÄÁ¢Ê §À¡õÅÃ¢ì¸¡ Â¡ø”. 
- அக திய   ணவாகட  
 
Activities: 
· Astringent 
· Laxative 
· Fungicidal 
· Bactericidal  
 
Uses: 
It is used in fever, cough, rheumatism, urinary tract diseases, and scorpion Stings. 
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¾¡ýÈ¢ì¸¡ö 
Botanical Name : Terminalia bellerica (Gaertn.)Roxb. 
Family  : Combretaceae 
Parts used  : Fruit, seed, leaf 
 
Organoleptic characters: 
Taste : Bitter 
Potency : Hot 
Pirivu : Sweet 
Phytochemicals: 
· Gallo-tanic acid 
· Resin 
 
¦À¡Ð Ì½õ 
 
“¬½¢ô¦À¡ý §ÁÉ¢ì ¸ÆÌõ ´Ç¢ÔÁ¢Ìõ 
§¸¡½¢ì¦¸¡û Å¡¾À¢ò¾ì¦¸¡û¨¸§À¡õ - ¾¡É¢ì¸¡ö 
¦¸¡ñ¼Å÷ìÌ §Á¸ÁÚõ ÜÈ¡ «ÉüÈ½¢Ôõ 
¸ñ¼Å÷ìÌ Å¡¾õ§À¡õ ¸¡ñ”. 
- அக திய   ணவாகட  
 
Therapeutic actions: 
· Astringent 
· Laxative 
· Tonic 
· Expectorant 
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Uses: 
It is used in cough, hoarseness of voice, eye diseases. 
 
ÍìÌ 
Botanical name : Zingeber officinale,Rosc 
Parts used  : Dried rhizome 
 
ORGANOLEPTIC CHARACTERS 
 
Taste: Kaarppu 
Potency: Veppam 
Division: Kaarppu 
 
¦À¡Ð Ì½õ 
#iyke;jk; neQ;nrhpg;G NjhlNk gk;koiy 
%yk; ,iug;gpUky; %f;FePh; - thyfg 
Njhlkjp rhue; njhlh;thj Fd;kePh;j; 
Njhlk;M kk;Nghf;FQ; Rf;F. 
- அக திய   ணவாகட  
 
THERAPEUTIC ACTIONS: 
· Stimulant 
· Carminative 
· Stomachic 
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Chemical constituents: 
Volatile oils (bisabolene, borneol, camphene, cineol, citral, citronellol, geranial, 
limonene, linalool, phellandrene, zingiberene, zingiberol). The aromatic principles are 
bisabolene and zingiberene; the pungent principles are gingerols and shogaols which are 
anti-nausea. Gingerols turn into shogaols when exposed to heat and air. 
Other ingredients: Calcium, capsaicin, curcumin, high in iron and calcium, limonene, 
linoleic acid, magnesium, phosphorus, potassium, riboflavin, vitamin B6, vitamin C, 
zingibain, ginger has proteases (GP-I and GP-II) that are similar to digestive aids 
bromelain 
 
¦ÅûÙûÇ¢ 
Botanical name     :   Allium sativum.Linn 
Family                   :   Lilliaceae 
Parts used            :   Tuber  
 
Organoleptic Characters 
Taste:  Kaarppu 
Potency: Veppam 
pirivu   :  Kaarppu  
 
¦À¡Ð Ì½õ 
              “ºýÉ¢¦Â¡Î Å¡¾ó ¾¨Ä§¿¡× ¾¡ûÅÄ¢ 
                ÁýÉ¢ÅÕ ¿£÷ì§¸¡¨Å Åýº£¾õ- «ýÉ§Á! 
                ¯ûÙûÇ¢ ¸ñÀ¡ö ¯¨ÇãÄ §Ã¡¸Óõ §À¡õ 
                ¦ÅûÙûÇ¢ ¾ýÉ¡ø ¦ÅÕñÎ. “ 
 
                                                         அக திய   ணவாகட  
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Therapeautic Action 
· Carminative 
· Stomachic  
· Anthelmintic  
· Diuretic 
· Tonic 
· Stimulant 
 
Uses 
 It cures vaatha diseases, headache, jaw pain, sinusitis, delirium and piles. 
 
Å¡öÅ¢¼í¸õ 
Botanical name : Emblica ribes.Burm.f 
Family  : Myrsinaceae 
Parts used  : Seed 
 
ORGANOLEPTIC CHARACTERS 
Taste: Kaippu 
Potency: Veppam 
Division: Kaarppu 
 
¦À¡Ð Ì½õ 
ghz;LFl;lk; Fd;kk; gUe;J}y Neha;thje; 
jPz;L jphptplQ; rpue;Jz;lk; - G+z;lkb 
Neha;tpsq;ff; fhl;lhj Ez;fpUkp ahrdg;Gz; 
tha;tpsq;fq; fhl;ltpUkhh;. 
 - அக திய  ணவாகட  
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Therapeautic Action 
 Anthelmintic 
 Carminative 
 Stomachic 
 Stimulant 
 
USES: 
It is used in the treatment of anaemia, skin diseases, peptic ulcer, obesity, 
poisonous bites, vaatha diseases, diseases of the head and diseases caused by micro 
organisms like bacteria, virus etc., 
 
Studies already done in Vaai Vidangam: 
Anti oxidant activity and Neuroprotective activity: 
Chronic treatment with ethanolic E.ribes extract enhanced the antioxidant defense 
against MCAO- induced focal cerebral ischemia in rats and exhibited neuroprotective 
activity (Ansari et al., 2008). [Ref: Article - Phytochemical and Pharmacological Review 
of Adhatoda zeylanica and Embelia ribes] 
 
ÅºõÒ 
Botanical Name         :  Acorus calamus, Linn. 
Family                        :   Araceae. 
Parts used                  :   Root tuber. 
Organoleptic Charecters 
                         Taste :  Kaarppu. 
                      Potency :  Veppam. 
                         Pirivu :  Kaarppu. 
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¦À¡Ð Ì½õ 
               “ À¡õÀ¡¾¢ ¿ïºü Ò¾ôÒñ ÅÄ¢Å¢¼À¡¸í ÌýÁõ 
                ÝõÀ¡ Ã¢Ãò¾À¢ò ¾õÓ¸ ¿¡üÈõÅý Ý¨ÄºýÉ¢ 
               Å£õÀ¡õ¨À ¸¡ºõ À¢Ä£¸ï º¢Ä¢À¾õ Å£È¢ÕÁø 
              ¾¡õÀ¡í ¸¢ÕÁ¢ Â¢¨Å§ÂÌ Á¡º¢Å ºõÀ¢¨É§Â.”  
- ேதர    ணவாகட  
Therapeautic Actions 
· Stimulant  
· Stomachic 
· Antiperiodic 
· Carminative  
· Nauseant  
· Emetic  
· Disinfectant  
· Germicide 
Uses  
It cures vaatha diseases, peptic ulcer, hypertention, delirium, cough, liver diseases, 
hook worm infestation, fillariasis, all types of toxins including snake bite and extreme 
painful condition.   
 
Áïºû 
Botanical name : Curcuma longa.Linn 
Family  : Zingiberaceae 
Organoleptic characters 
· Suvai - Kaarppu, Kaippu 
· Thanmai - Veppam 
· Pirivu – Kaarppu 
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¦À¡Ð Ì½õ 
¾¨ÄÅÄ¢ ¿£§ÃüÈï º¨ÇÂ¡¾ §Á¸õ 
¯¨Ä×¾Õ À£Éºò¾¢ ë§¼- ÅÄ¢ÍÃôÒ 
Å¢ïÍ ¸ÊÅ¢¼Óõ Å£ÚÅ¢Ã ½í¸Ùõ§À¡õ 
Áïºû ¸¢ÆíÌìÌ Á¡ø 
 
Action 
· Carminative 
· Hepatic tonic 
· Stimulant 
Uses 
· It cures poisonous bites, 
· Headache, 
· Sinusitis, 
· Leucorrhoea, 
· Tridhodam, 
· Ulcer. 
 
±ÕìÌ  
Botanical name : Calotropisgigantea (Linn) R.Br 
 Family  : Asclepidaceae 
Organoleptic character 
· Suvai - Kaippu, Kaaram, Mathuram 
· Thanmai - Veppam 
· Pirivu - Kaaram 
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¦À¡Ð Ì½õ 
±Ä¢Å¢¼í Ìð¼¨ÁÂ §ÁÚ ¸¢ÕÁ¢ 
ÅÄ¢Ý¨Ä Å¡ÔÅ¢¼ Áó¾õ -ÁÄÀó¾õ 
±øÄ¡ Á¸Ö ¦ÁÕì¸¢¨Ä ¨Âì¸ñ¼¡ø 
Å¢øÄ¡÷ Ñ¾§Ä! Å¢ÇõÒ. 
- அக திய   ணவாகட  
Action 
· Anthilmentic 
· Alterative 
· Laxative 
· Stimulant. 
 
Uses 
· Cures Leprosy, 
· Worm infestations, 
· Swelling of Joints, 
· Vaatha disease, 
· Constipation, 
· Antidote for Rat bite, Snake poison. 
 
¿ø¦Äñ¦½ö 
Botanical name : Sesamum indicum, Linn. 
Family  : Papillonaceae. 
Parts used  : Seed Oil. 
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ORGANOLEPTIC CHARACTERS 
Taste: kaarppu 
Potency: Veppam 
Division: kaarppu 
 
¦À¡Ð Ì½õ 
Gj;jpeadq; Fsph;r;rp G+hpg;G nka;GsfQ; 
rj;Jtq; fe;jp jdpapsik – nkj;jTz;lhk; 
fz;Nzha; nrtp Neha; fghytoy; fhrNeha; 
Gz;Nzha;Ngh nkz;nza;ahw; Nghw;W. 
 - அக திய  ணவாகட  
 
THERAPEUTIC ACTIONS: 
· Demulcent 
· Emollient 
· Nutritive 
· Anti-inflammatory 
Oil extracted from sesame seed is used as a coolant and to cure skin ailments, eye 
diseases, ear ache, ulcers etc. 
 
USES: 
· The oil from the nutrient rich seed is popular in alternative medicine Ancient Indian 
medical system perceives sesame oil to pacify stress related symptoms. 
· Sesame oil is a source of vitamin E.Vitamin E is an anti-oxidant and is said to lower 
cholesterol. 
· As with most plant based condiments; sesame oil contains magnesium, copper, calcium, 
iron, zinc, and vitamin B6. 
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ÀÍõÀ¡ø 
COW’S MILK 
LACTUS, MILK AND MILK PRODUCTS 
 
General Properties: 
 
ghyh; fpoth; goQ;Ruj;Njhh; Gz;zhsp 
#iyah; Nkfj;Njhh; Jh;gyj;Njhh; VYkpth; 
vy;yhhf;F khFk; ,isj;jth;f;FQ; rhjfkha; 
ey;yha; gRtpd;ghy; ehl;L. 
- Fzghlk; jhJ [Pt tFg;G. 
 
It is a good nutritive supplement for new born, young adults and older adults. It cures 
vaatha diseases, veneral diseases, and also useful in the treatment of emaciated 
individuals. 
 
Other aspects about milk: 
Milk is a translucent white liquid produced by the mammary glands of mammals, 
a pH ranging from 6.4 to 6.8, making it slightly acidic. Cow’s milk is the primary source 
of nutrition for young mammals before they are able to digest other types of food. Cow’s 
milk contains, on an average, 3.4% protein, 3.6% fat, and 4.6% lactose, 0.7% minerals 
and supplies 66 kcal of energy per 100 grams. The largest structures in the fluid portion 
of the milk are casein protein micelles 
 
Nutrients in a cup of milk(250 ml): 
Nutrients (either naturally or through fortification) including: 
· Biotin 
· Pantothenic acid 
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· Iodine 
· Potassium 
· Magnesium 
· Selenium 
· Thiamine 
· Vitamin A 
· Vitamin B12 
· Riboflavin 
· Vitamin D 
· Vitamin K 
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Perarathai 
 
 
Nelli Vatral 
 
 
Vai Vidangam 
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Thippili moolam 
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Mara Manjal 
 
Sukku 
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Aayilpattai 
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Ghee 
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Sugar 
 
Milk 
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STANDARD OPERATING PROCEDURE 
PARANGIPATTAI RASAYANAM  AND  LASUNATHY THYLAM 
 
SOURCE OF RAW DRUGS: 
           The required raw drugs for preparation of PARANGIPATTAI RASAYANAM 
AND LASUNATHY THYLAM are purchased from a well reputed country shop.The 
raw drugs are authenticated by the medicinal department of NIS. The raw drugs are 
purified and medicine is prepared in Gunapadam lab of National Institute of Siddha. The 
prepared medicine is again authendicated by head of the department of gunapadam 
 
1. PARANGIPATTAI  RASAYANAM 
INGREDIENTS 
Parangipattai – Smilax china .Linn – 16 balam (560 grms) 
Kodiveli - Plumbago zeylanica   
Sanguver – Clitoria ternatea ,linn. 
Amukaraa – Withania somnifera (linn) dunal 
Nilappanai – Curculigo orchiodes .gaertn 
Thipilimoolam - Root of Piper longum, Linn. 
Thalisapathiri - – Abies spectabilis (d.don) mirb 
Lavangapathiri –Cinnamomum tamala (buch,hum) nees. 
Milagu - Piper nigrum,Linn. 
Thipili - Piper longum,Linn. 
Omam – Carum capticum benth andhook.f. 
Kurosaaniomam – Hyoscyamus niger Linn 
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Kaurunjeeragam – Nigella sativa,Linn. 
Sitharathai - Alpinia officinarum (Linn) wild 
Perarathai -  Alpinia galanga (Linn) wild 
Kadukkai - Terminalia chebula, Retz 
Thaanrikai - Terminalia bellarica.(Gaertn) Roxb 
Nellimulli - Phyllanthus emblica,Linn 
Sevviyam - Root of Piper nigrum, Linn. 
Vaalmilagu – Piper cubeba .lin f 
Kozhtam - Costus specius,(Koenig ex Retz) J.E.Smith 
Kasakasa – Papaver somniferum Linn. 
Malli – Coriandrum sativum ,Linn. 
Jadaamanjil – Nardostachys grandiflora ,dc. 
Kiraambu – Syzygium aromaticum (Linn)merrill and perry 
Saathikaai – Myristica fragrans houtt 
Lavangapattai – Cinnamomum verum , presl 
Sukku - Zingiber officinale, Rose. 
Above all the drug each - ½ balam (17.5 gms) 
Ghee    - 2 padi ( 4litre ) 
Sugar    - 2 saer (560 gms ) 
 Cow’s Milk   - sufficient amount 
Honey    - 1padi (2 litres) 
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METHOD OF PURIFICATION: 
Plumbago zeylanica : Root bark is powdered and boiled in milk for 3 hours. 
Piper longum root : The nodes are plucked and cleaned from the root and dried 
Piper nigrum  : The fruits are soaked in sour butter milk for three hours, then 
dried and collected.  
Piper longum  : It is soaked in lemon juice 
Zingiber officinalis : (dried Ginger) and limestone are taken in a ratio 1:2 and fried for 
3 hrs, washed and the outer skin is removed and collected. 
Carum capticum fruit : It is soaked in limestone water and dried. 
Hyoscyamus niger : The dust particles are removed and collected. 
Nigella sativa  :  The drug is fried to golden brown colour and collected. 
Piper cubeba  : The pedicle is removed and collected. 
Costus speciosus root :  It is cleaned and dried. 
Coriandrum sativum : It is wrapped with a piece of cloth and subjected to steam bath 
with hot water. 
Terminalia chebula :  It is soaked in rice water, dried and taken after removing the 
seeds.  
Embilica officinalis : It is boiled in milk and the seeds are removed. 
Terminalia bellarica : It is soaked in  the root juice of Clerodendrum phlomoidis for 
three hours and the seeds are removed . 
Acorus calamus : It is burnt in flame and collected.  
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Roots: (General method) 
a. Wash the roots with running water and dry it. 
Barks: (General method) 
b. Clean the barks with cotton cloth and remove the peel with small knife and 
dry it. 
                               
METHOD   OF PREPARTION:   
The above mentioned drugs are purified properly as said above and they are dried 
in shade and made into fine powder. 
The above mixture content is mixed with ghee, sugar, honey and then stored in a 
suitable container. 
 
LASUNATHY THYLAM 
INGREDIENTS:  
Vellulli – Allium sativum, linn.  - 1 padi (2litr) 
Arathai – Alpinia galanga (linn) wild - 1/2 palam (17.5gms) 
Vaaivilangam – Embelia ribes,F.Burm -  1/2 palam ( 17.5gms) 
Vasambu – Acorus calamus. Linn  - 1 /2palam ( 17.5gms) 
Sevviyam - Root of Piper nigrum, Linn. - 1 palam ( 35gms ) 
Manjal  - Curcuma longa,Linn.  - 1 palam ( 35gms ) 
Maramanjal - Coscinium fenestratum,(Gaertn)Colebr-1 palam ( 35gms ) 
Milagu   -  Piper nigrum,Linn   -  3 palam ( 105gms ) 
Thipilimoolam -  Root of Piper longum, Linn.  -  3 palam ( 105gms ) 
Murungai  –   Root of Moringa oleifera lam. -  1/4 palam ( 8.75gms ) 
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Nochi   –  Root of Vitex negundo,linn.  -  1/4 palam ( 8.75gms ) 
Kandankathiri –  Root of Solanum surattense,Burn.f. - 1/4 palam ( 8.75gms ) 
Mulli   –  Root of Hygrophila auriculata  -  1/4 palam ( 8.75gms ) 
Erukkampoo  –  Root of Calotropis gigantea (linn )R.Br - 1/4 palam ( 8.75gms ) 
Aayilpattai  –  Root of Chukrasia tabularis,a.juss  - 1/4 palam ( 8.75gms ) 
Kodiveli  –  Root of Plumbago Zeylanica  .linn  - 1/4 palam ( 8.75gms ) 
Gingelly oil -   4 padi (8 litr ) 
 
Method of preparation of LASUNATHY THYLAM 
All the ingredients are grinded and mixed with gingely oil and heated up to the 
consistency of oil (thaila patham)   
 
DRUG STORAGE 
      The trial drug PARANGIPATTAI RASAYANAM (Internal medicine) is stored in 
clean and dry glass bottles and LASUNATHY THYLAM (External medicine) is stored 
in clean and dry narrow mouthed bottles. 
 
DISPENSING 
      Parangipattai Rasayanam given in sachets (24pakets are given in each visit,with a 
single paket containing  6gms each )  and oil is given in glass bottles. 
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TRIAL DRUGS : 
1. PARANGIPATTAI  RASAYANAM  ( INTERNAL) 
DOSAGE   :  Pakkalavu -6 gms, twice a day 
ADJUVANT   : MILK 
COURSE   : 24 DAYS 
Diet Advice (pathiyam) : Avoid Tamarind,Smoking,Sexual contact     
2. LASUNATHY THYLAM (External medicine)        
DOSAGE:  Sufficient quantity (50 ml apply) 
method of drug administration:  Applied externally over the affected part. 
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CLINICAL STUDY 
STUDY DESIGN  and  CONDUCT OF STUDY: 
Study type              :  An open clinical trial 
Study place            :  OPD.and IPD  of Ayothidass pandithar hospital ,  
                                   National institute of Siddha, 
                                   Tambaram sanatorium, Chennai-47.                                                            
Study period           : 12 months 
Sample size             : 40 patients 
 
SUBJECT SELECTION 
                As and when patients reporting at OPD of Ayothidass Pandithar hospital with 
symptoms of inclusion criteria will be subjected to screening test and documented using 
screening proforma. 
INCLUSION CRITERIA 
· Age :25-65Yrs 
· Sex : Both male and female 
· Patients having symptoms of  Acute shoulder joint  pain, benumbed feeling and 
wasting in the shoulder region and arms, restricted  movements of upper limb,  
loss of abduction and  forward flexion followed by stiffness of the shoulder joint 
and dizziness. 
· Patients who are willing   to give   radiological investigation and provide blood 
for lab investigation. 
· Patient willing to sign the informed consent stating that he/she will 
conscientiously stick to the treatment during 24days but can opt out of the trial 
of his/her own conscious discretion.  
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 EXCLUSION CRITERIA 
· Rheumatoid arthritis 
· Cardiac disease 
· Renal disease 
· Hypertension 
· Diabetes mellitus 
· Use of narcotic drugs 
· Pregnancy and lactation 
· Any other serious illness 
· Cervical spondylosis 
 
WITHDRAWAL CRITERIA 
· Intolerance to the drug and development of serious adverse reactions during drug 
trial. 
· Poor patient compliance and defaulters. 
· Patient turned unwilling to continue in the course of clinical trial. 
· Occurrence of any serious illness 
 
TESTS AND ASSESMENTS 
A. Clinical assessment  
Siddha assesment 
B. Laboratory Investigations 
1. Routine investigations 
2. Specific investigations 
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A. CLINICAL ASSESMENT 
  Acute shoulder joint pain 
   Benumbed feeling 
  Wasting in the shoulder region and arms 
   Restricted movement of the upper limb  
   Loss of abduction 
  Loss of forward flexion  
  Stiffness of the shoulder joint 
  Dizziness 
 
SIDDHA ASSESSMENT 
Thinai (Living Place): 
Paruvakaalam (Season): 
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Gnanenthiriyam and Kanmenthiriyam: 
1. Vaai (Buccal Cavity) 
2. Kaal (lower limb) 
3. Kai (upper limb) 
4. Eruvaai (anorectal region) 
5. Karuvaai (uro- genital region) 
 
Ezhu Udal Kattugal: 
1. Saram 
2. Senneer 
3. Uoon 
4. Kozhuppu 
5. Enbu 
6. Moolai 
7. Sukkilam/Suronitham 
 
Enn Vagai Thervu (Eight types of Examination): 
1. Nadi (Pulse perception) 
2. Naa (Tongue) 
3. Niram (Complexion) 
4.  Mozhi (Voice) 
5. Vizhi (Eyes) 
6. Parisam (Palpatory perception) 
7. Malam (Bowel habits) 
8. Moothiram (Urine){Neerkuriand Neikuri} 
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1. ROUTINE INVESTIGATION 
BLOOD  
· Hb (gm/dl )                                                                                                                                                                               
 
· Total WBC Count( Cells/cumm)      
· DC-  Polymorphs(%)                        
· Lymphocytes (%) – 
· Eosinophils(%) – 
· Monocytes(%) – 
· Basophils (%)– 
· Total RBC count(Million cells / cumm)-  
· ESR(mm/hr)- 
· Blood glucose( mg/dl):  ( Fasting)    
                                     :  ( Post – prandial)- 
LIPID PROFILE 
· Serum cholesterol(mg/dl)- 
·  HDL cholesterol(mg/dl)- 
·  LDL cholesterol(mg/dl)- 
· VLDL cholesterol(mg/dl)- 
· Serum triglycerides  (mg/dl)-    
 
RENAL FUNCTION TESTS 
· Blood urea (mg/dl)- 
· Serum Creatinine (mg/dl)- 
· Uric acid (mg/dl)- 
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LIVER FUNCTION TESTS 
· Serum total bilirubin (mg/dl)  -      
· Serum Direct bilirubin (mg/dl) -       
· Serum Indirect bilirubin (mg/dl) -       
· Serum Alkaline phosphotases (u/l) - 
· SGOT (u/l) - 
· SGPT (u/l) - 
· Serum Total Protein   ( g/dl) - 
· Serum Albumine( g/dl) - 
· Serum Globulin( g/dl) - 
· Serum Calcium (mg/dl) -       
· Serum Phosphorous (mg/dl) -       
                        
URINE 
 
· Urine sugar (F)and(PP) 
· Albumin 
· Deposits 
      
MOTION 
· Ova  
· Cyst 
· Occult blood 
 
2. SPECIFIC INVESTGATIONS 
o X - Ray of affected Shoulder  joints (AP and  supero - inferior view of 
shoulder joint )  
o ECG 
3. OTHER INVESTGATIONS             CRP  , RA factor 
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STUDY ENROLLMENT  
§ Patients reporting at NIS  OPD with the clinical symptoms of  Acute Shoulder 
joint pain, benumbed feeling and wasting in the shoulder region and arms, 
restricted movements of upper limb,  loss of abduction and  forward flexion 
followed by stiffness of the shoulder joint and dizziness.etc will  be examined 
clinically for enrolling in the study based on the inclusion and exclusion criteria.  
§ The patients who are to be enrolled in the study will be informed (Form IV- B) 
about the study, trial drug, possible outcomes and the objectives of the study in 
own language and terms understandable to them. 
§ After ascertaining the patient’s willingness, informed consent will be obtained in 
the consent form (Form IV- C). 
§ All these patients will be given unique registration card in which patients’ 
Registration number of the study, Address, Phone number and Doctors phone 
number etc. will be given, so as to report easily should any adverse reactions arise. 
§ Complete clinical history, complaints and duration, examination findings-- all will 
be recorded in the prescribed Proforma in the history and clinical assessment 
forms separately. Screening Form- I will be filled up; Form I-A, Form –II , Form 
–II-A and Form –III will be used for recording the patients’ history, clinical 
examination of symptoms and signs and laboratory investigations respectively. 
§ Patients will be advised to take the trial drug and appropriate dietary advice (Form 
IV-D) would be given according to the patients’ perfect understanding. 
 
CONDUCT OF THE STUDY: 
         Treatment commences with purgation by giving Agasthiar Kuzhambu - 130 mg od 
(at early morning) with ginger juice 
         The trial drug PARANGIPATTAI RASAYANAM (Internal) is given 6 gms twice 
a day with milk for 24 days continuously. 
          The trial drug LASUNATHY THYLUM (External) is given continuously for 24 
days for external application 
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          For OP patients, they should visit the hospital once in 12 days.  At each clinical 
visit clinical assessment is done and prognosis is noted.  
          For IP patient’s clinical assessment and prognosis is noted daily. 
          Laboratory investigations are done 0th day and 24 th day of the trial for both OP 
and IP patients   .  
           For IP patients, who is not in a situation to stay in the hospital for a long time is 
advised to attend the OPD for the continuation of the treatment. After the end of the 
treatment also, the patient is advised to visit the OPD for another 2months for follow-up. 
If any trial patient who fails to collect the trial drug on the prescribed day but wants to 
continue in the trial from the next day or two, he/ she will be allowed, but defaulters of 
one week and more will not be allowed to continue and be withdrawn from the study with 
fresh case being included. 
 
DATA MANAGEMENT 
· After enrolling the patient in the study, a separate file for each patient will be 
opened and all forms will be filed in the file. Study No. and Patient No. will be 
entered on the top of file for easy identification. Whenever study patient visits 
OPD during the study period, the respective patient file will be taken and 
necessary recordings will be made at the assessment form or other suitable 
form. 
· The screening forms will be filed separately. 
· The Data recordings will be monitored for completion and adverse event by 
HOD and Sr. Research Officer (Statistics). All forms will be further scrutinized 
in presence of Investigators by Sr. Research Officer (Statistics) for logical 
errors and incompleteness of data to avoid any bias. No modification in the 
results is permitted for unbiased reports. 
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STATISTICAL ANALYSIS: 
 
All collected data will be entered into the computer and manually cross-checked 
the correctness of the data entry. The clinical symptoms and pain scale will be analysed 
by comparing the two point of data (before and after treatment) paired test and chi-square 
test will be employed to study the efficacy of treatment. Futher, the effect of age and sex 
will also be analyzed. 
 
OUTCOME 
PRIMARY OUTCOME 
            Outcome is pain mainly assessed by Universal Pain Assessment Tool -Numeric 
Rating Scale before and after treatment 
 
PAIN ASSESMENT: 
 
UNIVERSAL PAIN ASSESMENT TOOL 
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Numeric Rating Scale (0-10) for pain: 
0-1 No pain 
 2 Mild pain (can be ignored) 
3-5    Moderate pain (interferes with tasks) 
5-7 Moderate pain (interferes with concentration) 
7-9 severe pain (interferes with basic needs) 
10  Worst pain (bed rest required) 
 
SECONDARY OUTCOME: 
1. Reduction in other symptoms 
2. Siddha co factors   
3. Changes in investigation parameter 
 
 ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT: 
                                 If the trial patient develops any adverse reaction. It will be recoreded 
in adverse reaction form, and he/she would be immediately referred to member of 
pharmacovigilance department of NIS  and proper management will be given  by the 
investigator in OPD of National institute of siddha.  
 ETHICAL ISSUES 
1. Informed consent will be obtained from the patient explaining in the understandable 
language to the patient. 
2. After the consent of the patient (through consent form) they will be enrolled in the study.  
3. Treatment would be provided free of cost.  
4. No other external or internal medicines will be used. There will be no infringement on the 
rights of patient.    
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5.To prevent any infection, while collecting blood sample from the patient, only disposable 
syringes, disposable gloves, with proper sterilization of lab equipments will   be used. 
6.The data collected from the patient will be kept confidentially. The patient will be 
informed about the diagnosis, treatment and follow-up. 
7.In conditions of treatment failure, adverse reactions, patients will be given alternative 
treatment at the National Institute of Siddha with full care throughout the end.        
 
ASSESSMENT FORM 
 
FORM I  SCREENING AND  SELECTION PROFORMA 
FORM I A  A HISTORY PROFORMA ON ENROLLMENT 
FORM ll  CLINICAL ASSESSMENT ON ENROLLMENT 
FORM ll A  CLINICAL ASSESSMENT DURING AND AFTER TRIAL 
FORM lll LABORATORY INVESTIGATION ON ENROLLMENT AND 
CONCLUSION OF TRIAL 
FORM IV A  DRUG COMPLIANCE FORM  
FORM IV B  INFORMATION SHEET  
FORM IV C  CONSENT FORM 
FORM IV D  DIETARY ADVICE FORM 
FORM IV E  WITHDRAWAL FORM 
FORM IV F  ADVERSE REACTION FORM 
  
93 
 
OBSERVATIONS AND RESULTS 
Results of the study were observed with respect to the following criteria; 
1. Age distribution 
2. Gender distribution 
3. Occupation 
4. Paruva Kaalam (Seasonal changes) 
5. Diet 
6. Thegi 
7. Thinai 
8. Duration of Illness 
9. Socio economic status 
10. Derangement of  Vaatham 
11. Derangement of  Pitham 
12. Derangement of  Kabam 
13. Derangement of Envagai Thervugal 
14. Naadi 
15. Neerkuri 
16. Neikuri analysis 
17. Derangement of Udal thathukkal 
18. Gunam 
19. Derangement of Gnanenthiriyam 
20. Derangement of Kanmenthiriyam 
21. Kosangal 
22. Clinical features  
23. Result of treatment 
24. Lab investigation 
94 
 
1. AGE: 
AGE No. of Patients PERCENTAGE 
25 - 35 8 20.00% 
36 - 45 12 30.00% 
46 - 55 12 30.00% 
56 - 65 8 20.00% 
TOTAL 40 100% 
 
 
  
Inference:    
          Among the 40 patients admitted for the trial, occurrence of the disease was found to 
be higher (30%) in the age group between 35-45 years.             
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2. GENDER: 
 
GENDER 
No. of 
patients 
PERCENTAGE 
Male 16 40% 
Female 24 60% 
Total 40 100% 
 
 
 
 
 
Inference:    
           Among the 40 patients admitted for the trial, the occurrence of the disease was 
found to be higher in females (24 cases) (60%)  
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3. OCCUPATION:   
OCCUPATION No. of Patients PERCENTAGE 
Driver 1 2.50% 
Coolie 9 22.50% 
Engineer 2 5.00% 
Mechanic 3 7.50% 
Tailor 2 5.00% 
Home maker 23 57.50% 
Total 40 100% 
 
 
 
Inference: 
 23 patients affected were Home makers (57.50%), 9(22.5%) patients were Coolie 
workers, 3(7.5%) patients were Mechanic, 2(5%) Tailors and one Engineer,1 
(2.5%)patients were Driver. 
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4. PARUVA KAALAM (SEASON) : 
PARUVA KAALAM No. of Patients PERCENTAGE 
Kaar kaalam 0 0.00% 
Koothir kaalam 0 0.00% 
Munpani kaalam 0 0.00% 
Pinpani kaalam 0 0.00% 
Ilavenil kaalam 24 60.00% 
Mudhuvenil kaalam 16 40.00% 
Total 40 100% 
 
 
 
Inference:    
Incidence of the disease is higher in Ilavenil kalam (60%) than in Mudhuvenil 
kalam (40%). 
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5. DIET 
DIET No. of Patients PERCENTAGE 
Vegetarian 2 5% 
Non-Vegetarian 38 95% 
Total 40 100% 
 
 
 
Inference: 
 Among 40 patients, 2 patients (5%) were Vegetarians and 38 patients (95%) were 
Non-vegetarians. 
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6. THEGI: 
Thegi No. of Patients PERCENTAGE 
Vaatham 0 0.00% 
Pitham 6 15.00% 
Kabam 3 7.50% 
Thontham 31 77.50% 
Total  40 100% 
 
 
 
Inference: 
 Among 40 patients, 31 patients (77.50%) had Thontha udal, 6 patients 
(15%) had Pitha udal and 3 patients (7.5%) had Kaba udal. 
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7. THINAI: 
THINAI No. of Patients PERCENTAGE 
Kurinji 1 2.50% 
Mullai 1 2.50% 
Marutham 9 22.50% 
Neithal 29 72.50% 
Paalai 0 0.00% 
Total 40 100% 
 
 
 
Inference:    
72.5% of patients were reported from Neithal nilam, 22.5% of patients were 
reported from Marutham nilam and 2.5 % were from Kurinji and Mullai nilam. 
 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
Kurinji Mullai Marutham Neithal Paalai
2.50% 2.50%
22.50%
72.50%
0.00%
Pe
rc
en
ta
ge
Thinai
Thinai
101 
 
8. DURATION OF ILLNESS: 
DURATION OF ILLNESS No. of Patients PERCENTAGE 
Up to 6 months 30 75.00% 
7 – 12  months 7 17.50% 
13 –18 months 0 0.00% 
19 – 24 months 3 7.50% 
Total 40 100% 
 
 
 
Inference:   
Among 40 patients, 30 (75%)  patients were suffering from this illness for up to 6 
months, 7 patients (17.50%) were affected between 7 to 12 months and 3 patients (7.50%) 
were affected between 19 to 24 months. 
 
0.00%
20.00%
40.00%
60.00%
80.00%
Up to 6 
months
7 – 12  
months
13 –18 
months
19 – 24 
months
75.00%
17.50%
0.00%
7.50%Pe
rc
en
ta
ge
Duration of Illness
DURATION OF ILLNESS
102 
 
9. SOCIO ECONOMIC STATUS: 
SOCIO ECONOMIC STATUS No. of Patients PERCENTAGE 
Lower 23 57.50% 
Middle 14 35.00% 
High 3 7.50% 
Total 40 100% 
  
 
 
 
Inference:    
The occurrence of the disease was found to be higher in socio economically lower 
class (57.50%). 
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10. DISTURBANCES IN VAATHAM: 
VAATHAM 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Abanan 3 0 3 100.00% 
Uthanan 0 0 0 0.00% 
Viyanan 40 0 40 100.00% 
Samanan 39 0 39 100.00% 
Koorman 3 3 0 0.00% 
Devaathathan 1 0 1 100.00% 
 
Inference:       
Viyanan and Samanan vayus (pain and restricted movents in the shoulder joints) 
were affected in all the 40 (100%) patients. Abana vayu was affected ( constipation ) in 3 
(7.5%) patients and koorman (dull vision) in 3(7.5%), devaathathan (sleeplessness) in 
1(2.5%)  patient. All the patients got relieved from symptoms exept Koorman (dull 
vision). 
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11. PITHAM: 
PITHAM 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Anarpitham 1 0 1 100.00% 
Ranjagam 0 0 0 0.00% 
Sathagam 40 1 39 97.50% 
Prasagam 0 0 0 0.00% 
Alosagam 0 0 0 0.00% 
 
 
 
Inference:    
In Pitham, anarpitham (loss of appetite ) was affected in 1(2.5%) patient and 
Sathaga pitham (cant do day today activitys) in 40(100%) patients. After treatment, 39 
(97.5%) patients got relieved from symptoms of Sathaga Pitham. 
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12. KABAM: 
KABAM 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Avalambagam 0 0 0 0.00% 
Klaethagam 0 0 0 0.00% 
Bothagam 0 0 0 0.00% 
Santhigam 40 6 34 85.00% 
Tharpagam 0 0 0 0.00% 
 
 
 
Inference:    
All the 40 (100%) patients were affected by Santhigam (shoulder joint pain). After 
treatment, 34 patients (85%) got relieved from the symptoms. 
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13. ENVAGAI THERVUGAL 
a.  NAA: 
Naa 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Coating 12 0 12 100.00% 
Pallor 2 0 2 100.00% 
Normal 26 26 26 100.00% 
 
 
Inference: 
 Among the 40 (100%) patients, coating of the tongue was seen in 12(30%) 
patients, Pallor was seen in 2 (5%) patients and 26 (65%) patients had normal tongue. 
After treatment all the patients had normal tongue. 
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b. MALAM 
Malam 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Constipation 3 0 3 100.00% 
Stool bulk 3 0 3 100.00% 
Consistency 3 0 3 100.00% 
 
 
Inference: 
 Before treatment, constipation was seen in 3 (7.5%) patients, stool bulk was seen 
in 3(7.5%) patients and the stools were consistent in 3(7.5%) patients. After treatment, 
Malam was normal in all the patients. 
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14. NAADI 
NAADI No. of Patients PERCENTAGE 
Vali 0 0.00% 
Azhal 3 7.50% 
Vali Azhal 25 62.50% 
Azhal Vali 7 17.50% 
Iyya Vali 4 10.00% 
Iyya Azhal 1 2.50% 
Total 40 100% 
 
 
 
Inference:   
Among 40 patients, Vali Azhal Naadi was seen in 25 patients (62.50%), Azhal 
Naadi was seen in 3 patients (7.50%), Azhal Vali Naadi was seen in 7 patients (17.50%), 
Iyya Vali Naadi was seen in 4 patients (10%) and Iyya Azhal Naadi was seen in one 
patient (2.50%). 
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15. NEERKURI 
NEERKURI 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Niram 15 0 15 100.00% 
Manam 0 0 0 0.00% 
Nurai 0 0 0 0.00% 
Edai 0 0 0 0.00% 
Volume 0 0 0 0.00% 
 
 
Inference: 
 Among 40 patients, Niram (yellow coloured urine) was seen in 15(37.5%) 
patients. After treatment, Niram had become normal in all the patients who were affected. 
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16. NEIKURI: 
NEIKURI No. of Patients PERCENTAGE 
Pearl Beaded Fashion 29 72.50% 
Serpentine Fashion 11 27.50% 
Mixed Fashion 0 0.00% 
Total 40 100% 
 
  
 
Inference:   
 Among 40 patients, pearl beaded fashion was seen in 29 (72.50%) patient’s urine, 
Serpentine fashion was seen in 11 (27.50%) patient’s urine. 
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17. SEVEN UDAL THATHUKKAL: 
UDAL 
THATHUKKAL 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED BEFORE TREATMENT 
      AFTER 
TREATMENT 
Saaram 2 1 1 50.00% 
Senneer 2 1 1 50.00% 
Oon 40 4 36 90.00% 
Kozhuppu 40 1 39 97.50% 
Enbu 40 6 34 85.00% 
Moolai 0 0 0 0.00% 
Sukkilam/Suronitham 0 0 0 0.00% 
 
 
Inference:   
Enbu thathu was affected in all the 40 patients (100%) It is due to the involvement 
of glenoid cavity of scapula and humerus. Saaram (general tiredness) was affected in 2 
patients (50%) and 1 patient was normal after treatment, Senneer (pallor) in 2 
patients(50%) and 1 patient was normal after treatment, Oon (spasmodic pain) and 
kozhupu (restricted movements in shoulder joints) in 40 patients (100%). 36 patients 
recovered from spasmodic pain and 39 patients recovered from restricted movements in 
shoulder joints. 
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18. Gunam: 
Gunam No. of case Percentage 
Sathuva gunam 0 0% 
Rasatha gunam 40 100% 
Thamo gunam 0 0% 
Total 40 100% 
 
 
Inference:     
All the 40 cases, (100%) were found to posses Rasatha gunam. 
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19. GNANENTHIRIYAM : 
GNANENTHIR
IYAM 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOM
S 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Mei 12 0 12 100.00% 
Vai 3 3 0 0.00% 
Kann 3 3 0 0.00% 
Mooku 0 0 0 0.00% 
Sevi 0 0 0 0.00% 
 
 
 
Inference: 
 Before treatment, Mei was affected in 12 (30%) patients, vai was affected in 
3(7.5%)  patients and kann was affected in 3(7.5%) patients. After treatment, Mei became 
normal in all the patients. But patients who were affected by vai and kann remain 
affected. 
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20. KANMENTHIRIYAM: 
KANMENTHIRI
YAM 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOM
S 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Kai 40 0 40 100.00% 
Kaal 2 0 2 100.00% 
Vai 2 2 0 0.00% 
Eruvai 3 0 3 100.00% 
Karuvai 0 0 0 0.00% 
 
 
 
 
Inference:   
Kai was affected in all the 40 (100%)  patients, and all the cases were relieved 
from the symptoms after treatment.  Kaal was affected in 2 (5%) patients, and the 
symptoms were relieved after treatment. Eruvai was affected in 3 (7.5%) patients, and the 
symptoms were relieved after treatment. Vai was affected in 2 (5%)  patients, no one got 
relieved from th symptoms after treatment. 
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21. KOSANGAL: 
KOSANGAL 
No. of  Patients PATIENTS 
RELIEVED 
FROM 
SYMPTOMS 
PERCENTAGE 
OF PATIENTS 
RELIEVED 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Annamaya 
Kosam 0 0 0 0.00% 
Pranamaya 
Kosam 0 0 0 0.00% 
Manomaya 
Kosam 0 0 0 0.00% 
Vignanamaya 
Kosam 40 8 32 80.00% 
Ananthamaya 
Kosam 0 0 0 0.00% 
 
 
Inference: 
 Among 40 patients, Vignanamaya kosam deranged in all the 40(100%) patients. 
After treatment, 8 (20%) patients were affected by Vignanamaya kosam. Remaining 32 
(80%) patients had good relief. 
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22. CLINICAL FEATURES: 
Clinical Features No. of Patients Percentage 
Pain in Shoulder 40 100.00% 
Swelling in Shoulder 4 10.00% 
Benumbed feeling of Shoulder joints 39 97.50% 
Restricted movements 40 100.00% 
Minimal tenderness 40 100% 
 
 
 Inference:   
All 40 (100%) patients had pain in the shoulders, restricted movements, minimal 
tenderness, 39 (97.5%) have benumbed feeling and only 4 had swelling in shoulder.  
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23. PROGNOSIS : 
Clinical 
Features 
No. of Patients 
No. of Patients 
Recovered 
Percentage of 
Patients 
Recovered 
PRE 
TREATMENT 
POST 
TREATMENT 
Pain in Shoulder 40 4 36 90.00% 
Swelling in 
Shoulder 4 0 4 100.00% 
Benumbed 
feeling of 
Shoulder joints 
39 0 39 100.00% 
Restricted 
movements 40 1 39 97.50% 
Minimal 
tenderness 40 0 40 100.00% 
Early Morning 
Stiffness 26 1 25 96.15% 
 
 
 Inference:   
 Among 40 (100%) patients 36 (90%) got relieved from pain and all the 40 patients 
got relieved from minimal tenderness in the shoulders, all 4 got relieved from swelling in 
the shoulder joints, all 39 got relieved from benumbed feeling and 39 got relieved from 
restricted movements. 
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a.Nature of Pain: 
Nature of Pain 
No. of Patients 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Mild 0 8 
Moderate 32 0 
Severe 8 0 
Total 40 8 
 
 
Inference: 
 Before treatment, 32(80%) patients were affected by moderate pain, 8(20%) 
patients were affected by severe pain. After treatment, 8 (20%) patients had relieved from 
severe pain to mild pain. 
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b.Aggravating factor on Movement: 
 
Aggravating factor on 
Movement 
No. of Patients Percentage of 
Patients 
Relieved 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Yes 40 0 0% 
No 0 40 100% 
Total 40 40 100% 
 
 
 
Inference: 
 Before treatment, all the 40 patients (100%) had pain on movements. After 
treatment, all the 40 patients (100%) got relieved. 
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c.Relieving factor – Rest: 
Relieving factor - Rest 
No. of Patients 
Percentage of 
Patients Relieved BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Yes 17 38 95.00% 
No 23 2 5.00% 
Total 40 40 100.00% 
 
 
Inference: 
 After treatment, 38 patients (95%) got relieved during rest. 
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d.Restriction in shoulder joints: 
Restriction Shoulder 
Joints 
No. of Patients 
Percentage of 
Patients Relieved BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Partial 29 1 2.50% 
Fully 11 0 0.00% 
No 0 39 97.50% 
Total 40 40 100.00% 
 
 
 
Inference: 
 Before treatment 29 (72.5%) patients had partial restriction of movements in the 
shoulder joints and 11(27.5%) patients had restriction fully. After treatment only one had 
partial restriction and remaining 39 (97.5%) patients got relieved from shoulder 
restrictions. 
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24.LAB INVESTIGATIONS: 
ESR: 
ESR No. of patients % of patients 
No. of patients ESR reduced 27 67.50% 
No. of patients ESR not reduced 13 32.50% 
Total 40 100.00% 
 
 
 
Inference: 
 Out of 40 patients, ESR got reduced in 27 patients after treatment but in 13 patients it 
remained the same 
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STATISTICAL ANALYSIS 
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross-tabulations were 
performed. The quantity variables were expressed as Mean ± Standard Deviation and 
qualitative data as percentage. A probability value of <0.05 was considered to indicate as 
statistical significance. Paired‘t’ test was performed for determining the significance 
between before and after treatment. 
  Mean Std Deviation Significant 
Before 5.58 1.318 
p<0.0001 
After 0.33 0.694 
 
Inference: 
 The Mean ± Standard Deviation of pain score at before and after treatment were 
5.58 ± 1.318 and 0.33 ± 0.694 respectively which is statistically highly significant 
(p<0.0001). 
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DISCUSSION 
 
Kumbavaatham has increased in incidence now days due to various life style 
modifications. Severity of the disease attracts the attention of physicians to implement 
various therapies. Numerous medicines have been tried previously for treating this 
condition. Taking into account the indication of trial drugs in sastric texts and 
pharmacological activities of ingredients, they were chosen for study. 
The internal medicine Parangipattai Rasayanam was analyzed methodically. 
Biochemical and pharmacological analysis were done. Acute and subacute toxicity 
studies were carried out to confirm the safety of the drug. The biochemical markers of 
liver and kidney function tests did not show evidence of liver and kidney toxicity. There 
was no significant change in biochemical parameters like blood cholesterol, blood sugar. 
No significant changes in body weight, food, water intake were observed in drug treated 
animals when compared to controls. 
The treatment was aimed to normalize the deranged kuttram and to provide relief 
from the symptoms.  Before treatment the patients were advised to take Agasthiyar 
Kuzhambu-130 mgs with zinger juice, during early morning for purgation followed by 
rest on that day.  The next day onwards treatment with the trial drug PARANGIPATTAI 
RASAYANAM (internal) 6gm twice daily for 24 days with milk and LASUNATHY 
THAILAM (external) 50ml for external appication 
During treatment, the patients were advised to follow pathiyam (diet restrictions). 
40 patients were admitted for trial, among whom 30 were out-patients and 10 were 
in-patients. Progress of the patients was documented regularly. 
 Various criteria like gender predominance, incidence of the disease with respect 
to the age, kaalam (seasonal variation) and diet were assessed. Clinical manifestation and 
assessment of the improvement in the prognosis of the disease with trial drugs were taken 
into account for evaluating the efficacy of trial drugs.  
The study reveals highest range of occurrence of disease between the age of 36 – 
45(30%) and 46-55 (30%) among 40 patients . It is due to the degenerative changes in 
this age group.  
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Females (60%) are affected more than males among study sample. This may be 
due to increased work load and deficiency state of nutrients.  
Among the 40 patients, home makers were in higher percentage 57.5%,                    
persons in cooly 22.5% occupation is followed by mechanics 7.5%, engineers (5%), 
tailors (5%). drivers (2.5%), Heavy house-hold works act as an aggravating factor in 
home makers. 
Highest occurrence 60% was reported in Ilavenil kaalm and 40% was reported 
during mudhuvenil kaalam. According to Siddha literature, the Vaatha kuttram attains 
thannilai valarchi (mild derangement) during Mudhuvenil kaalam. 
Among 40 patients, 2 patients (5%) were Vegetarians and 38 patients (95%) were 
Non-vegetarians. 
Among 40 patients, 31 patients (77.50%) had Thontha udal, 6 patients (15%) had 
Pitha udal and 3 patients (7.5%) had Kaba udal. 
72.5% of patients were reported from Neithal nilam, 22.5% of patients were 
reported from Marutham nilam and 2.5 % were from Kurinji and Mullai nilam. 
Among 40 patients, 30 (75%)  patients were suffering from this illness for up to 6 
months, 7 patients (17.50%) were affected between 7 to 12 months and 3 patients (7.50%) 
were affected between 19 to 24 months. 
On considering the socio-economic status, 57.5% patientsof study sample were 
from lower income group, 35% were from middle income group and the remaining 7.5% 
were from high income group. 
Viyanan and Samanan vayus (pain and restricted movents in the shoulder joints) 
were affected in all the 40 (100%) patients. Abana vayu was affected ( constipation ) in 3 
(7.5%) patients and koorman (dull vision) in 3(7.5%), devaathathan (sleeplessness) in 
1(2.5%)  patient. All the patients got relieved from symptoms exept Koorman (dull 
vision). 
In Pitham, anarpitham (loss of appetite ) was affected in 1(2.5%) patient and 
Sathaga pitham (cant do day today activitys) in 40(100%) patients. After treatment, 39 
(97.5%) patients got relieved from symptoms of Sathaga Pitham. 
All the 40 (100%) patients were affected by Santhigam (shoulder joint pain). After 
treatment, 34 patients (85%) got relieved from the symptoms. 
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Among the 40 (100%) patients, coating of the tongue was seen in 12(30%) 
patients, Pallor was seen in 2 (5%) patients and 26 (65%) patients had normal tongue. 
After treatment all the patients had normal tongue. 
Before treatment, constipation was seen in 3 (7.5%) patients, stool bulk was seen 
in 3(7.5%) patients and the stools were consistent in 3(7.5%) patients. After treatment, 
Malam was normal in all the patients. 
Among 40 patients, Vali Azhal Naadi was seen in 25 patients (62.50%), Azhal 
Naadi was seen in 3 patients (7.50%), Azhal Vali Naadi was seen in 7 patients (17.50%), 
Iyya Vali Naadi was seen in 4 patients (10%) and Iyya Azhal Naadi was seen in one 
patient (2.50%). 
Among 40 patients, Niram (yellow coloured urine) was seen in 15(37.5%) 
patients. After treatment, Niram had become normal in all the patients who were affected. 
In Neikkuri Examination (Oil on urine sign), serpentine fashion was seen in 
27.5% patientsand pearl fashion was seen in 72.5% patients  
Enbu thathu was affected in all the 40 patients (100%) It is due to the involvement 
of glenoid cavity of scapula and humerus. Saaram (general tiredness) was affected in 2 
patients (50%) and 1 patient was normal after treatment, Senneer (pallor) in 2 
patients(50%) and 1 patient was normal after treatment, Oon (spasmodic pain) and 
kozhupu (restricted movements in shoulder joints) in 40 patients (100%). 36 patients 
recovered from spasmodic pain and 39 patients recovered from restricted movements in 
shoulder joints. 
All the 40 cases, (100%) were found to posses Rasatha gunam. 
Among 40 patients of the trial 100% patients were reported with pain in the 
shoulder joints and restricted movements and Minimal tenderness and 97.5% of patients 
reported benumbed feeling of Shoulder joints and 10% reported Swelling in the Shoulder 
joints 
Before treatment, Mei was affected in 12 (30%) patients, vai was affected in 3(7.5%)  
patients and kann was affected in 3(7.5%) patients. After treatment, Mei became normal 
in all the patients. But patients who were affected by vai and kann remain affected. 
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Kai was affected in all the 40 (100%)  patients, and all the cases were relieved 
from the symptoms after treatment.  Kaal was affected in 2 (5%) patients, and the 
symptoms were relieved after treatment. Eruvai was affected in 3 (7.5%) patients, and the 
symptoms were relieved after treatment. Vai was affected in 2 (5%)  patients, no one got 
relieved from th symptoms after treatment. 
Among 40 patients, Vignanamaya kosam is affected (pain and restricted 
movements in shoulder joints) in all the 40(100%) patients. After treatment, 8 (20%) 
patients were affected by Vignanamaya kosam. Remaining 32 (80%) patients were 
relieved. 
Laboratory investigation of blood and urine were done for all 40 patients prior to 
and after trial. There were  significant changes in ESR and Hb parameters. Pre-treatment 
and post-treatment results of Liver function tests and renal function tests were normal. 
The radiographic studies of the patientsshowed presence of osteophytic changes. 
The trial drug showed reduction in clinical signs and symptoms rather than any changes 
in radiographic studies. 
After treatment, 90% patients recovered from pain in the shoulder joints and 
97.5% recovered from Restricted movements and 100% recovered from Minimal 
tenderness and Benumbed feeling of Shoulder joints and Swelling in the Shoulder joints. 
 
OUTCOME MEASURES: 
PRIMARY OUTCOME OBSERVATIONS: 
  NATURE OF PAIN : (PAIN ASSESSMENT SCALE-ANNEXURE I) 
Among 40 cases, 
As per the numerical Pain assessment scale, 
In 32 (80%) cases there was no pain after treatment. 
In 8 (20%) cases there was mild pain after treatment. 
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IMPROVEMENT IN PAIN ASSESSMENT PER PATIENT: 
Among 40 cases have shown reduction in pain after the completion of treatment. Hence                        
*The range of improvement varies  as stated below 
8 (20%) cases had improved  2 grades after treatment. 
32(80%) cases had improved 1 grade after treatment 
 
SECONDARY OUTCOME OBSERVATIONS: 
 
I. CLINICAL SYMPTOMS. 
 Observation with reference to Clinical symptoms: 
a. Pain: 
Among the total number of 40 cases,   
§ In 32 (80%) cases there was complete relief of pain. 
§ In 8 (20%) of cases there was reduction in pain. 
b. Aggravating factor on movements: 
    Among the 40 cases, 40 (100%) cases were pain aggravating on movements before 
treatment.  
    but 
§ In 40 (100%) cases there was no pain aggravating on movements after treatment. 
c.Releiving factor – during  Rest : 
Among the 40 cases, 17 cases were pain relieved during rest  and 23 cases were  no pain 
relieved during rest  before treatment 
§ In 38 (95%) cases were pain relieved during rest  after treatment. 
§ In 2 (5%) cases were no  pain relieved during rest  after treatment 
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d.Restriction of shoulder joints : 
 Among the 40 cases, 29 cases were partial restriction movement in the shoulder 
joints present and 11 cases were fully restriction movement in the shoulder joints 
present before treatment  
But 
· In 39 (97.5%) cases were no restricted movement in the shoulder joints after 
treatment 
· In 1 (2.5%) cases were partisl  restricted movement in the shoulder joints present  
after treatment 
 
STATISTICAL ANALYSIS: 
 
I. PAIN ASSESSMENT SCALE BEFORE AND AFTER TREATMENT. 
Bio Statistical Analysis 
 The clinical trials of the drug PARANGIPATTAI  RASAYANAM(Internal) and 
LASUNATHY THAILAM (External) are differentiated in terms of percentages. The 
effectiveness of the drug is assessed by using paired comparison test (paired t test). The 
responses (intensity of pain) of the patients to the drug are analyzed.  
Assessment of the effectiveness of drug: 
 The effectiveness of the drug was assessed by the relief of the patients from pain, 
and which is measured using a standard pain scale. 
 INFERENCE: The test drug is is highly statistically significant (p<0.0001) and 
hence effective in reducing the pain 
 
2. ERTHROCYTE SEDIMENTATION RATE (ESR) 
Though there was improvement in 22 patients (55%), there was no significant 
increase after the treatment statistically 
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HAEMOGLOBIN 
Though there was improvement in 31 patients (77.5%), there was no significant 
increase after the treatment statistically 
Biochemical analysis: 
       Qualitative analysis reveals parangipattai rasayanam contains, nitrates, 
sulfates, tanic acid, Iron, Calcium, unsaturated compounds. 
· Quantitative analysis  revealed that it contains chiefly 
 
Ca 317.933 246.249 mg/L 
Cu 324.754   8.255 mg/L 
Fe 238.204 16.985 mg/L 
K 766.491    120.159 mg/L 
Mg 257.610 19.578 mg/L 
P 214.914     77.995 mg/L 
Si 251.611 17.249 mg/L 
S 181.975  64.654 mg/L 
Zn 213.856 23.756 mg/L 
· SEM – Micro graph partical size – 8 -  17 micron 
 
TOXICITY STUDY: 
 
ACUTE TOXICITY: 
Acute toxicity studies done in National Institute of Siddha, as per WHO guide 
lines revealed the safety of the drug in oral dose  (12g – Single day human dose ) as it did 
not produce any adverse effects in the animals. There were no abnormalities detected in 
the internal organs on necropsy.  
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SUBACUTE TOXICITY:  
Subacute toxicity studies done in National Institute of Siddha, as per WHO guide 
lines did not reveal any adverse effects in the animal. Animal behavior, food and water 
intake, defaecation, urination etc , did not reveal any abnormality. histopathological 
examination did not show any abnormal variations. 
Hence it can be concluded from the study that up to maximum dose 
(1800mg/animal) the drug was proved to be safe. 
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SUMMARY 
v The aim of the study is to evaluate the safety and efficacy of trial drug for 
Kumbavaatham 
v Institutional Ethical Committee (IEC) of National Institute of Siddha (NIS) had 
given approval to the project entitled Safety and Efficacy of parangipattai 
rasayanam (internal), lasunathy thailam (external) in KumbaVaatham. Approved 
IEC No:NIS/IEC/2011/3/08 - 24/12/2011 
v Institutional Animal Ethical Committee (IAEC) had approved for animal study. 
Approved IAEC No: 1248/ac/09/CPCSEA/4-08/2011 - 20/12/2011. 
v The raw drugs were authenticated by the concerned department and the trial drug 
was prepared by the investigator in the Gunapadam lab of National Institute of 
Siddha as per the Standard Operating Procedure mentioned in the protocol. 
v The medicine was then subjected to pre clinical toxicity studies (Acute and long 
term toxicity studies) as per the protocol and the safety of the drug was ensured. 
v The qualitative and quantitative bio chemical studies were done at the bio 
chemistry lab of National Institute of Siddha and IIT Chennai respectively 
v For the clinical study 40 cases were selected based on the Inclusion criteria and 
Exclusion criteria, Out of 40 cases, 30 cases were treated in OPD and 10 cases 
were treated in IPD of Ayothidass Pandithar Hospital, National Institute of 
Siddha, Chennai-47. 
v Clinical diagnosis of kumbaVaatham was done by Siddha and Modern 
methodologies. 
v Informed Consent was obtained from the Patients before starting the treatment. 
v Investigations were carried out before and after the treatment. 
v The day before starting the trial drug treatment  Agasthiyar Kuzhambu - 130 mgs 
with zinger juice, during early morning for purgation followed by rest on that day, 
was given to correct the elevated kuttrams. 
v The clinical trial was conducted in 40 patients of kumbavaatham the drug 
PARANGIPATTAI RASAYANAM (internal) 6gm twice daily for 24 days 
with milk and LASUNATHY THAILAM (external) 50ml for external 
appication. 
v Diet restriction was strictly followed during the period of drug administration as 
well as re dieting period (Diet free of salt, tamarind etc) is noted in the form IV D 
(Dietary advice form).  
133 
 
v Clinical assessments were made daily in the IPD cases and 12 days once in OPD 
cases and observation were noted in the concerned forms.  
v During the study period there was no adverse drug reactions occur. 
v Among 40 cases, 90% patients recovered from pain in the shoulder joints and 
97.5% recovered from restricted movements and 100% recovered from Minimal 
tenderness and benumbed feeling of Shoulder joints and Swelling in the Shoulder 
joints. 
v The results of the study reveal the fact that these medicines are efficacious in 
reducing pain, benumbed fleeing and restriction of movements in kumbavaatham 
v As per the Siddha Literature and modern science reviews and research articles, the 
ingredients of the trial drugs were found to have the property of controlling the 
Vaatha diseases, some drugs exhibited anti inflammatory and analgesic action 
owing to the disease manifestations 
v In case of Clinical Lab parameters there was reduction in ESR which showed the 
therapeutic effect of the drug in controlling the disease to a greater extent. 
v Qualitative analysis reveals parangipattai rasayanam contains, nitrates, sulfates, 
tanic acid, Iron, Calcium, unsaturated compounds. 
v Statistical analysis showed significant reduction in pain scale before and after the 
treatment.  (p<0.0001) 
v Oral toxicity studies conducted ensured the safety usage of the drug to animals up 
to a maximum dose of 1800 mg/animal. 
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CONCLUSION 
 
v Siddha literature is treasured with numerous formulations of medicines for various 
disease conditions. This study was done with the sastric medicines 
PARANGIPATTAI RASAYANAM (internal) and LASUNATHY THAILAM 
(external). These are indicated for vaatha diseases in the texts. 
v Among 40 cases, 90% patients recovered from pain in the shoulder joints and 
97.5% recovered from restricted movements and 100% recovered from Minimal 
tenderness and benumbed feeling of Shoulder joints and Swelling in the Shoulder 
joints. 
v The results of the study reveal the fact that these medicines are efficacious in 
reducing pain, benumbed fleeing and restriction of movements in kumbavaatham. 
v The safety studies (the acute toxicity and subacute toxicity) studies conducted 
revealed that the trial drug was safe even at higher dosage of 1800 mg/animal. 
There were no abnormalities found in histopathological examination .Hence it can 
be reasonably assumed that the drug is safe for human. 
v Statistical analysis showed significant reduction in pain scale before and after the 
treatment.  (p<0.0001) 
v There was a reduction in the elevated lab parameters ESR after the treatment 
revealing the contol of the disease 
v There were no adverse reactions complained during the trial 
v Because of the encouraging clinical outcome, the study may be further carried out 
with the same drug in a large number of cases 
v Thus it is concluded the medicines PARANGIPATTAI RASAYANAM                   
(internal) and LASUNATHY THAILAM (external) reducing pain, benumbed 
fleeing and restriction of movements in kumbavaatham. 
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Qualitative phytochemical analysis of Acidic/Basic radicals and constituents in test 
drugs 
Preliminary Qualitative analysis of drug –Parangipattai rasayanam 
ANALYSED AT NATIONAL INSTITUTE OF SIDDHA 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of sample Brown  in colour  
2. Solubility: 
a. A little (500mg) of the sample 
is shaken well with distilled water. 
b. A little (500mg) of the sample 
is shaken well with con. HCl/Con. 
H2So4. 
Completely soluble Absence of Silicate 
3. Action of Heat: 
   A small amount (500mg) of the 
sample is taken in a dry test tube and 
heated gently at first and then strong. 
 
White fumes   
evolved 
 
Absence of Carbonate 
4. Flame Test: 
  A small amount (500mg) of the 
sample is made into a paste with con. 
HCl in a watch glass and introduced 
into non-luminous part of the Bunsen 
flame. 
 No Bluish green 
flame appeared. 
Absence of Copper 
5. Ash Test:s  
   A filter paper is soaked into a 
mixture of sample and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited 
 No Yellow colour 
flame 
Absence of Sodium 
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Preparation of Extract:   
5gm of parangipattai rasayanam is weighed accurately and placed in a 250ml 
clean beaker and added with 50ml of distilled water. Then it is boiled well for about 10 
minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml 
with distilled water. 
S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1.  Test For Sulphate: 
2ml of the above prepared extract is taken in a test 
tube to this added 2ml of 4% dil ammonium 
oxalate solution. 
 Cloudy 
appearance 
present 
Present 
2. Test For Chloride: 
2ml of the above prepared extracts is added with 
2ml of dil-HCl is added until the effervescence 
ceases off. 
No Cloudy 
appearance 
present 
Absent 
3. Test For Phosphate: 
2ml of the extract is treated with 2ml of 
dil.ammonium molybdate solution and 2ml of 
con.HNo3. 
No Yellow 
appearance 
present 
Absent 
4.  Test For Carbonate: 
2ml of the extract is treated with 2mldil. 
magnesium sulphate solution. 
No Cloudy 
appearance 
present 
 
Absent  
5. Test For Nitrate: 
1gm of the substance is heated with copper turning 
and concentrated H2So4 and viewed the test tube 
vertically down. 
No Brown gas is 
evolved 
Present 
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6. Test For Sulphide: 
1gm of the substance is treated with 2ml of con. 
HCL 
No Rotten Egg 
Smelling gas 
evolved 
Absent 
7. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil. Acetic acid 
and 2ml dil.calcium chloride solution and heated. 
No Cloudy         
appearance 
Absent 
8. Test For Nitrite: 
3drops of the extract is placed on a filter paper, on 
that-2 drops of dil.acetic acid and 2 drops of dil. 
Benzidine solution is placed. 
No 
Characteristic 
changes 
Absent 
9. Test For Borate: 
  2 Pinches (50mg) of the substance is made into 
paste by using dil.sulphuric acid and alcohol 
(95%) and introduced into the blue flame. 
Bluish green 
colour flame not 
appeared 
   Absent 
 II. Test For Basic Radicals   
1. Test For Lead: 
2ml of the extract is added with 2ml of 
dil.potassium iodine solution. 
No Yellow 
Precipitate is 
obtained. 
Absent 
2. Test For Copper: 
a. One pinch (50mg) of substance is made into 
paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the 
flame. 
No Blue colour 
flame 
No Blue colour 
precipitate 
formed. 
Absent 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium hydroxide is 
added in 5 drops to excess. 
No Yellow 
colour appeared 
  Absent 
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4. Test For Iron: 
a.To the 2ml of extract add 2ml of dil.ammonium 
solution 
b.To the 2ml of extract 2ml  thiocyanate solution 
and 2ml  of con HNo3 is added 
 
Mild Red colour 
appeared 
 
Present 
5. Test For Zinc:       To 2ml of the extract 
dil.sodium hydroxide solution is added in 5 drops 
to excess and dil.ammonium chloride is added.  
White precipitate 
is   not formed 
  Absent 
6. Test For Calcium:  
2ml of the extract is added with 2ml of 4% 
dil.ammonium oxalate solution  
 Cloudy 
appearance and 
white precipitate 
is obtained 
   Present 
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide solution is 
added in drops to excess. 
No White 
precipitate is  
obtained 
   Absent 
8. Test For Ammonium: 
  To 2ml of extract 1 ml of Nessler's reagent and 
excess of dil.sodium hydroxide solution are added. 
  No Brown 
colour appeared 
     Absent 
9. Test For Potassium:  
   A pinch (25mg) of substance is treated of with 
2ml of dil.sodium nitrite solution and then treated 
with 2ml of dil.cobalt nitrate in 30% dil.glacial 
acetic acid. 
 
No Yellowish 
precipitate is 
obtained. 
 
Absent 
10. Test For Sodium: 
    2 pinches (50mg) of the substance is made into 
paste by using HCl and introduced into the blue 
flame of Bunsen burner. 
 No Yellow 
colour flame 
appeared 
 Absent 
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11. Test For Mercury:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution.  
No yellow 
precipitate is 
obtained 
  Absent 
12. Test For Arsenic:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution. 
No brownish red 
precipitate is 
obtained 
Absent 
 
 
 
III. Miscellaneous 
 
 
 
 
1.
  
Test For Starch:  
2ml of extract is treated with weak dil.iodine 
solution  
 No Blue colour 
developed 
Absent 
2.
  
Test For Reducing Sugar:  
    5ml of Benedict's qualitative solution is taken in 
a test tube and allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract and again boil it 
for 2 minutes. The colour changes are noted. 
Brick red colour 
not developed 
Absent 
3.
  
Test For The Alkaloids: 
a) 2ml of the extract is treated with 2ml of 
dil.potassium lodide solution. 
b)  2ml of the extract is treated with 2ml of 
dil.picric acid. 
c)  2ml of the extract is treated with 2ml of 
dil.phosphotungstic acid. 
 
. 
  
No Yellow 
colour developed 
 
- 
 
  Absent 
4.
  
Test For Tannic Acid:  
  2ml of extract is treated with 2ml of dil.ferric 
chloride solution  
 No black 
precipitate is 
obtained 
    Present 
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5.
  
Test For Unsaturated Compound: 
  To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate is 
not decolourised 
   Absent 
6.
  
Test For Amino Acid: 
    2 drops of the extract is placed on a filter paper 
and dried well. 20ml of  Biurette reagent is added. 
 
No Violet colour 
developed 
   Absent 
7. Test For Type Of Compound: 
    2ml of the extract is treated with 2 ml of 
dil.ferric chloride solution.  
No green colour 
developed 
 
 
No red colour 
developed 
 
 
No violet colour 
developed 
 
 
No blue colour 
developed 
Absence of 
oxy quinole 
pinephrine 
and pyro 
catechol. 
Anti pyrine, 
Aliphatic 
amino acids 
and meconic 
acid are 
absent  
Apomorphin
e salicylate 
and 
Resorcinol 
are absent. 
 Morphine, 
Phenol cresol 
and 
hydrouinone
are absent 
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Interpretation of results 
S.NO CONSITUENTS INFERENCE 
1. Silicate Absent 
2. Carbonate Absent 
3. Copper Absent 
4. Sodium Absent 
5. Sulphate Present 
6. Chloride Absent 
7. Phosphate Absent 
8. Carbonate Absent 
9. Fluoride  Absent 
10. Oxalate Absent 
11. Nitrate Present 
12. Sulphide Absent 
13. Nitrite Absent 
14. Borate Absent 
15. Lead Absent 
16. Copper Absent 
17. Aluminium Absent 
18. Iron  Present 
19. Zinc Absent 
20. Calcium Present 
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21. Magnesium Absent 
22. Ammonium Absent 
23. Sodium Absent 
24. Mercury Absent 
25. Arsenic Absent 
26. Starch Absent 
27. Reducing Sugar Absent 
28. Alkaloids Absent 
29. Tannic acid Present 
30. Unsaturated 
Compound 
Present 
31. Amino acids Absent 
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PHYSIOCHEMICAL  PROPERTIES  OF  PARANGIPATTAI  RASAYANAM 
 
Table-1. 
Colour  characters of  Parangipattai rasayanam. 
 
S No 
 
Solvent used 
 
Under ordinary light 
 
Under ultra violet light 
1 PPM Brown Brown 
PPM-Powdered plant material 
 
Table-2. 
Physicochemical properties of Parangipattai rasayanam. 
 
S No. 
 
Parameters  
Values 
obtained 
(%w/w) 
Heavy/ toxic metals 
1 Total ash value  7.23 Lead BDL 
2 Acid insoluble ash  0.77 Cadmium BDL 
3 Water soluble ash  8.99 Mercury BDL 
4 Moisture content  10.12 Arsenic BDL 
5 Foreign organic matter  5.3 Volatile 
oil 
BDL 
6 Crude fibre content  20.5   
7 Alcohol soluble extractive  8.3   
8 Water soluble extractive  10.16   
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Table-3. 
Colour, nature and percent yields of extracts of Parangipattai rasayanam. 
 
S.no. 
 
Extract 
Solvents 
 
Colour 
 
TLC/GC 
(PEAKS)  
 
Nature 
 
 
       % 
Yield(w/w) 
 
SEM-Micro 
graph partical 
size range in 
micron 
 
pH 
1 Water brown 5 Solid      51 8 -17 micron 7.2 -7.3 
 
Table-4. 
Preliminary phytochemical analysis of different extracts of Parangipattai 
rasayanam 
 
S.no 
 
Phytoconstituents 
 
Aqueous 
 
1 Alkaloids + 
2 Flavonoids + 
3 Saponins - 
4 Glycosides + 
5 Carbohydrates + 
6 Amino acids   + 
7 Triterpenoids - 
 
 + = Present, − = Absent 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM, CHENNAI-36 
HR SEM-METHODOLOGY: 
An SEM is essentially a high magnification microscope, which uses a focussed 
scanned electron beam to produce images of the sample, both top-down and, with the 
necessary sample preparation, cross-sections. The primary electron beam interacts with 
the sample in a number of key ways:- 
· Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
· Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast.  
· Ionized atoms can relax by electron shell-to-shell transitions, which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few μm of the sample.  
SAMPLE PREPARATION: 
Sample preparation can be minimal or elaborate for SEM analysis, depending on 
the nature of the samples and the data required. Minimal preparation includes acquisition 
of a sample that will fit into the SEM chamber and some accommodation to prevent 
charge build-up on electrically insulating samples. Most electrically insulating samples 
are coated with a thin layer of conducting material, commonly carbon, gold, or some 
other metal or alloy. The choice of material for conductive coatings depends on the data 
to be acquired: carbon is most desirable if elemental analysis is a priority, while metal 
coatings are most effective for high resolution electron imaging applications. 
Alternatively, an electrically insulating sample can be examined without a conductive 
coating in an instrument capable of "low vacuum" operation.  
 The SEM is carried out by using FEI-Quanta FEG 200-High Resolution 
Instrument. 
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Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification: From a min of 12x to greater than 1, 00,000 X 
Application : To evaluate grain size, particle size distributions, material homogeneity   
   and  inter metallic distributions. 
 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
Sample preparation: 
                Sample preparation can be minimal or elaborate for SEM analysis, depending 
on the nature of the samples and the data required. Minimal preparation includes 
acquisition of a sample that will fit into the SEM chamber and some accommodation to 
prevent charge build-up on electrically insulating samples. Most electrically insulating 
samples are coated with a thin layer of conducting material, commonly carbon, gold, or 
some other metal or alloy. The choice of material for conductive coatings depends on the 
data to be acquired: carbon is most desirable if elemental analysis is a priority, while 
metal coatings are most effective for high resolution electron imaging applications. 
Alternatively, an electrically insulating sample can be examined without a conductive 
coating in an instrument capable of "low vacuum" operation. 
 
 
SEM – Micro graph partical size 
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TOXICOLOGICAL EVALUVATION OF PARANGIPATTAI 
RASAYANAM  
ACUTE TOXICITY STUDY OF PARANGIPATTAI RASAYANAM  
[WHO guidelines, 1993] 
Principle: 
Acute toxicity was carried out in Swiss albino mice with a single exposure of 10 
times of the recommended therapeutic dose of test compound. The study duration was 14 
days. 
Animal species  : Swiss albino mice 
Age / Weight / Size  :  6 weeks.  Mice-20-25 gms. 
Gender   :   Both male and female 
Number of Animals   : Mice: 20 
Acclimatization Period : 7 Days 
S.No Group No of mice 
1 Vehicle control 10  (5 male, 5 female) 
2 Toxic dose 10X therapeutic dose (180mg) 10  (5 male, 5 female) 
 
Test Animals  
Test animals were obtained from the animal laboratory of the King institute, 
Chennai and stocked at Animal house, National institute of Siddha, Chennai. All the 
animals were kept under standard environmental condition (27+ or – 2 degree c).The 
animals had free access to water and standard pellet diet (Sai meera foods pvt.ltd, 
Bangalore).The principles of laboratory animal care were followed and the  Institutional 
ethical committee approved the use of animals and the study design 
1248/ac/09/CPCSEA/4-08/2011 - 20/12/2011. 
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Route of administration: 
Oral route was selected, because it is the normal route of clinical administration. 
Test substance and vehicle 
The Parangipattai rasayanam is brownish  colour .The test substance was insoluble 
in water.  In order to the test drug  was mix with milk 
Administration of doses: 
Parangipattai rasayanam was Mix with milk ,with uniform mixing and it was 
administered to the group’s in a single oral dose. The control groups  received equal 
volume of the vehicle. The animals were weighed before giving the drug. The dose level 
was calculated according to body weight, and surface area. It was converted to animal 
dose (180mg) and then administered. The principle of laboratory animal care was 
followed. 
Observations 
Observations were made and recorded systematically and continuously observed 
as per the guideline after substance administration. Animals were observed individually. 
Visual observations included skin changes, alertness, grooming, aggressiveness, 
sensitivity to sound, touch and pain, restlessness, tremors, convulsion, righting reflex, 
gripping reflex, pinna reflex, corneal reflex, writhing reflex, papillary reflex ,urination, 
salivation, lacrimation for first 4 hrs, then periodically during the first 24 hrs. Animals 
were observed for body weight and mortality for 14 days. If animals dye during the 
period of study, the animals were sacrificed. At the end of the 14th day all animals were 
sacrificed and necroscopy was done. 
Body Weight 
Individual weight of animals were determined before the test substance was 
administered and daily for 14 days. Weight changes were calculated and recorded. At the 
end of the test surviving animals were weighed and sacrificed. 
Results: Parangipattai rasayanam at the dose 180mg/animal did not exhibit any 
mortality in mice. 
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No behavior changes were noted for the first 4 hours and for the next 24 hours and 
throughout the study period of 14 days. No weight reduction was noted before and after 
the acute study duration. Reflexes were found to be normal before and after the study. All 
other observations were found to be normal before and after the study. In Necropsy, the 
organs of the animal such as Liver, Heart, Lungs, Pancreas, Spleen, Stomach, Intestine, 
Kidney, Urinary bladder, Uterus all appeared normal. 
 
SUBACUTE  TOXICITY STUDY OF PARANGIPATTAI RASAYANAM: 
Animals             : Male and Female Wistar albino rats 
Age                     : 6-8 weeks 
Weight   : 150-200 gms 
Gender   :   Both male and female 
Number of animals   : Rat: 40 
Acclimatization period : 7 Days 
Clinical duration  : 28 days 
 
Animal source:      
Test animals were obtained from the animal laboratory of the King institute, 
Chennai, and stocked at Animal house, National Institute Of Siddha, Chennai. All the 
animals were kept under standard environmental condition (27+ or – 2 degree c) .The 
animals had free access to water and standard pellet diet (Sai meera foods pvt.ltd, 
Bangalore). The principles of laboratory animal care were followed and the Institutional 
ethical committee approved the use of animals and the study design.  
1248/ac/09/CPCSEA/4-08/2011 - 20/12/2011 . 
S. No Group No of Rats 
1 Vehicle control 10 (5male,5 female) 
2 1XTherapeutic dose (180mg) 10 (5male,5 female) 
3 5XTherapeutic dose (900mg) 10(5male,5 female) 
4 10XTherapeutic dose(1800mg) 10(5male, 5 female) 
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Identification of animal: 
By cage number, animal number and individual marking on fur. 
Housing and Environment: 
The animals were housed in polypropylene cages provided with bedding of husk 
.Dark and light cycle each of 12 hours. 
Administration period: 
The period of administration of the test substance to animals depends on the 
expected period of clinical use. Since the clinical dose of the test drug is 28 days and as 
per WHO guidelines. 
Dose selection: 
The results of acute toxicity studies in Swiss albino mice indicated that 
Parangipattai rasayanam was non toxic and no behavioral changes, mortality was 
observed. On the basis of these results, the doses were selected for the study as per WHO 
guidelines.  
Preparation and administration of dose:        
Parangipattai rasayanam was mixed with milk. It was administered to animals 
at dose levels of 1Xtherapeutic dose (180mg), 5XTherapeutic dose (900mg) and 
10XTherapeutic dose (1800mg).The control animals were administered milk only. 
Administration was by oral (gavage) once a day for 28 days. 
METHODOLODY: 
Randomization, numbering and grouping of animal: 
The animals were randomly divided into four groups for dosing up to 28 days. 
Each group consist of 10 animals (5 per sex in each group) were allowed acclimatization 
period of 7 days to laboratory conditions prior to the initiation of treatment. Each animal 
was fur marked with picric acid. The females were nulliparous and non pregnant. 
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OBSERVATION: 
Experimental animals were kept under observation throughout the course of study 
for the following:         
Body weight:  
Weight of each rat was recorded on day one and at weekly intervals throughout 
the course of study and at termination to calculate relative organ weights. From the data 
mean body weights and percent body gain were calculated. 
Food and water consumption: 
The quantity of food consumed by groups consisting of an animal for different 
doses were recorded at weekly intervals. Food consumed per animal was calculated for 
control and the treated dose groups. 
Clinical sings: 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of the symptom if any were recorded 
Mortality: 
All animals were observed twice daily for any mortality during entire course of 
study. 
HISTOPATHOLOGY: 
  Tissue samples of organs from control and treated animals were preserved in 10% 
formalin for preparation of sections using microtome. The organs included liver, kidneys, 
heart, lungs and stomach of the animals were preserved and they were subjected to 
histopathological examination. 
The organ pieces (3-5 micron ) were fixed in 10% formalin for 24 hours and 
washed in running water for 24 hours . Samples were dehydrated in tissue processor and 
then cleaned in benzene to remove absolute alcohol .Embedding  was done by passing the 
cleared sample through three cups containing molten paraffin at 50 degree c and then a 
cubical block of paraffin made by the L moulds it was followed by microtome and the 
slides were stained with haematoxylin–eosin stain .Stained sections of each organ were 
examined under light microscope at high (40X) power magnification. All the histo 
pathological slides were prepared at Dept .of. Pathology, vels university, Chennai. 
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HISTOPATHOLOGY PHOTOS  
 GROUP – I 
CONTROL 
GROUP – II 
(5 X ) 
GROUP – III 
(10 X) 
LIVER 
   
LUNGS 
   
KIDNEY 
   
STOMACH 
    
HEART 
    
SPLEEN 
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RESULT: 
 
180MG TREATED (Low dose) 
Kidneys: shows normal renal tissue with glomeruli and tubules.  
Spleen: shows normal spleen with lymphoid aggregation. 
Liver: shows almost normal hepatocytes and occasional binucleate cells. 
Stomach: shows normal mucosal glands. 
Lungs : shows normal alveoli. 
Heart: shows normal cardiac muscle bundles. 
Intestine: Shows normal Intestinal mucosal lining with mild exudates. 
Pancreas: shows normal acini with islets of β-cells 
Impression : normal study 
900MG TREATED (Mid dose) 
Kidneys: shows renal tissue with focal tubular damage, interstitial inflammatory 
collection. Glomeruli shows epithelial proliferation.  
Liver: shows hepatocytes with focal mild fatty change.  
Spleen: shows congestion with lymphoid hyperplasia.  
Stomach: shows near normal mucosal gland with mild exudates. 
Lungs : shows congested alveolar wall with mild thickening and mild emphysematous 
changes.  
Pancreas: shows pancreas with acini and normal islets.  
Heart: shows congestion and mild inflammatory infiltration in between cardiac muscle 
bundles. 
Intestine: Shows normal Intestinal mucosal lining with mild exudates. 
Impression : normal study 
1800MG TREATED (High dose) 
Stomach: shows stomach with superficial erosion and congestion.  
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Heart: shows hypertrophic cardiac muscle bundles.  
Spleen: shows lymphoid hyperplasia. 
Liver: shows marked dilatation of sinusoids, degeneration of hepatocytes, necrosis.   
Kidneys : shows renal tissue with tubular epithelial damage.  
Pancreas: shows atrophic islet cells. 
Lungs : shows congestion, narrowed alveolar space and thickened alveolar wall. 
Intestine: Shows normal Intestinal mucosal lining with mild exudates. 
Impression : normal study. 
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                                  NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
                                                 DEPARTMENT OF MARUTHUVAM 
A CLINICAL TRIAL TO ASSESS THE THERAPEUTIC EFFICACY OF PARANGIPATTAI 
RASAYANAM  &  LASUNATHY  THAILAM   in  KUMBAVATHAM  ( PERIARTHRITIS 
SHOULDER ) 
 
                                               FORM I  SCREENING & SELECTION PROFORMA 
 REG NO: 32101208/2012-13 
 
1. SI NO:------       2 OP /IP NO: --------- 3.NAME :------------    4.RELIGION : H / C / M / O 
 
5. AGE:-------       6.GENDER :-------        7.OCCUPATION :---------- 8. INCOME : ----------                
 
 INCLUSION CRITERIA 
Ø Age 25-65 yrs                                                                                                 Yes/No 
Ø Sex                                                                                                                  M/F 
Ø Patients having symptoms of  Acute shoulder joint  pain, benumbed feeling and wasting in the 
shoulder region and arms, restricted  movements of upper limb,  loss of abduction and  forward 
flexion followed by stiffness of the shoulder joint and dizziness.                          Yes/No 
Ø Patient willing to under go lab and radiological investigations                   Yes/No 
Ø Patient willingness for consent to include in the trial                                  Yes/No 
 EXCLUSION CRITERIA 
 
ADMITTED TO TRAIL :    YES                  NO             If Yes Serial NO:  
Date:                                                                                                                                                                                                                          
Signature of  the Investigator:                                                           Signature of the HOD 
 
Signature of the Lecturer: 
Rheumatoid 
arthritis 
Y/N Pregnancy &lactation Y/N Use narcotic drugs Y/N 
Renal diseases Y/N Diabetes mellitus Y/N Cervical spondylosis Y/N 
Hypertension Y/N Cardiac diseases Y/N Any other illness Y/N 
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AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
A CLINICAL TRIAL TO ASSESS THE THERAPEUTIC EFFICACY OF PARANGIPATTAI 
RASAYANAM  &  LASUNATHY  THAILAM   in  KUMBAVATHAM ( PERI ARTHRITIS 
SHOULDER ) 
 
 FORM l A      - HISTORY PROFORMA ON ENROLLMENT 
REG NO: 32101208/2012-13 
1. Serial No :   _______________                                             2. OP/IP No:---------- 
       
3. Name: ________________                                                    4. Gender:   Female/male 
 
5. Age (years): _________   DOB            
      Date       Month            Year 
6.Address:     -------------------------------------- 
                     ------------------------------------- 
                     -------------------------------------- 
 
7.A.Occupation:    -----------------------------                         B. Nature of work  ----------------- 
 
8. Educational  Status:   A) Illiterate                  B)Literate          
 
9.Height:           cms                10.Weight:           kg 
 
11. Complaints and Duration:   
________________________________________________________________________ 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
12. Habit of 
 
A) Smoking                   1. Yes; duration ________ years;    Number-                  2.No 
B) Alcoholism               1. Yes; duration ________ years;    Quantity-      ml       2.No 
C) Tobacco chewing     1. Yes; duration ________ years                                      2.No 
D) Betel chewing          1. Yes; duration ________ years                                      2.No 
 
13.Dietry style: A.Pure vegetarian           B.Non-vegetarian            C. Mixed diet 
 
14. Drug History: Had the patient been treated before with allopathy drug? A) Yes            B)No 
                                     
              Signature of the investigator 
              
              Signature of the lecturer                                                Signature of  HOD  
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AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
 A CLINICAL TRIAL TO ASSESS THE THERAPEUTIC EFFICACY PARANGIPATTAI RASAYANAM  &  
LASUNATHY  THAILAM   in  KUMBAVATHAM  ( PERI ARTHRITIS SHOULDER ) 
 
                       FORM II AND II-A    CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
         1. S NO -----------                                      2. OP/IP NO ------------------           REG NO: 32101208/2012-13 
         3.  NAME --------------- -------------                                                                     4.GENDER M/F                         
         5. DATE OF  ASSESSMENT   :    ---------------------- 
          Initial (0th day)                12th day               24th  day               
 
 SIDDHA SYSTEM OF EXAMINATION 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
     
 
 
 
 
 
 
 
 II. NAA:[TONGUE] 
 0th Day 12th Day 24th Day 
Colour Dark / Yellow/Red 
/ Pale/Normal 
Dark/Yellow/ 
Red/Pale/Normal 
Dark/Yellow/ 
Red/Pale/Normal 
Taste Sweet/Bitter/Sour 
Pungent/None 
Sweet/Bitter/Sour 
Pungent/None 
Sweet/Bitter/Sour 
Pungent/None 
Coating Present/Absent Present/Absent Present/Absent 
 0th  
day 
12th 
day 
24th 
day 
 0th  
day 
12th 
day 
24th  
day 
Vali     Iyya vali    
Azhal     Vali Iyyam    
Iyyam     Azhal Iyyam    
Vali Azhal     Iyya Azhal    
Azhal vali        
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Fissure Present/Absent Present/Absent Present/Absent 
Saliva Normal/Increased/ 
Decreased 
Normal/Increased 
Decreased 
Normal/Increased/ 
Decreased 
Dryness Present/Absent Present/Absent Present/Absent 
Glossitis Present/Absent Present/Absent Present/Absent 
Baldness Present/Absent Present/Absent Present/Absent 
III.NIRAM: [COMPLEXION]    
0th Day  12th day 24th Day 
Dark/Yellow 
tinted/Wheatish 
brown / Pale 
Dark/Yellow tinted  
/ Wheatish brown/ 
Pale 
Dark/Yellow tinted/       
Wheatish brown / 
Pale 
 
IV.MOZHI: [VOICE] 
0th Day  12th day 24th Day 
Medium/High 
Low pitched 
Medium/High/ 
Low pitched 
Medium/High/ 
Low pitched 
 
V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
0th Day  12th day 24th Day 
Yellow 
Red/ Pale/Normal 
Dark/Yellow 
Red/ Pale/Normal 
Dark/Yellow 
Red/ Pale/Normal 
   
VI. MALAM; [BOWEL HABITS / STOOLS] 
 0th Day 12th Day 24 th Day 
Colour Dark/ Yellow/ 
Pale/Others 
Dark/ Yellow/ 
Pale 
Dark/ Yellow 
Pale 
Consistency Solid/Semisolid 
Watery 
Solid/Semisolid 
Watery 
Solid/Semisolid 
Watery 
Stool  bulk                         Normal/Reduced 
 
Normal/Reduced Normal/Reduced 
Constipation   Present/Absent 
 
Present/Absent 
 
Present/Absent 
 
Diarrhoea Present/Absent Present/Absent Present/Absent 
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VII. URINE EXAMINATION:    
 
 
 
 
 
 
 
 
 
 
 
 
VIII. 
SPARISAM: [PALPATORY  PERCEPTION] 
0th Day 12th Day 24th Day 
Warmth/Cold/Normal 
 Sweat 
Warmth/ Cold/Normal 
Sweat 
Warmth/ Cold/Normal 
Sweat 
 
 
 
 
NEERKURI 0th Day 12th Day 24 th Day 
Niram 
[Colour]   
White/Yellowish/ 
Strawcoloured/ 
Crystal clear 
White/Yellowish/ 
Strawcoloured 
Crystal clear 
White/Yellowish/ 
Straw  coloured/ 
Crystal clear 
Manam 
[Odour] 
Present  
Absent 
 Present  
Absent 
Present  
Absent 
Nurai 
[Froth] 
Nil 
Reduced/Increased 
Nil 
Reduced/Increased 
Nil 
Reduced/Increased 
Edai 
[Sp.gra]                               
Normal 
Increased/Reduced 
Normal 
Increased/Reduced 
Normal 
Increased/Reduced 
Enjal 
[Deposits] 
Present/ Absent Present/ Absent Present/ Absent 
Volume   Normal 
Increased/Reduced 
Normal 
Increased/Reduced 
Normal 
Increased/Reduced 
NEIKURI 0th day 12th day 24th day 
Serpentine fashion    
Annular/Ringed fashion    
Pearl beaded fashion       
Mixed fashion    
Other fashion    
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5. THEGI: [ TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
 
6.NILAM: [ LAND WHERE PATIENT LIVED MOST ] 
  Kurinji                         Mullai                  Marutham              Neithal                  Palai 
(Hilly terrain)              (Forest range)          (Plains)                  (Coastal belt)        (Arid regions)  
 7. KAALAM 
Kaarkalam-                                 Pinpanikalam      
Koothirkalam-                            Ilavenil 
Munpanikalam -                         Muthuvenil 
8. GUNAM 
Sathuvam                        Rasatham                       Thamasam 
 
9. IMPORIGAL (SENSORY ORGANS) 
 
 
 
 
 
 
 
 
 
 0th day 12th day 24th day 
Mei  
(Skin) 
   
Vai 
(Buccal 
Cavity) 
   
Kann 
 (Eye) 
   
Sevi 
 (Ear) 
   
Mooku 
(Nose) 
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10. KANMENDRIYAM ( MOTOR ORGANS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11. KOSANGAL (Sheath)   
 0th day 12th day 24th day 
Annamaya 
 Kosam 
   
Pranamaya 
kosam  
   
Manomaya 
kosam  
   
 0th day 12th day 24th day 
Kai (upper 
limb) 
   
Kaal (lower 
limbs ) 
   
Vai   (buccal 
cavity) 
   
Eruvai 
(excretory 
organs) 
   
Karuvai  
(reproductiv
e organs) 
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Vignanamaya 
kosam  
   
Ananthamaya 
kosam  
   
 
12. MUKKUTRAM: [AFFECTION OF THREE HUMORS] 
A)VATHAM: 
 0th day 12th day 24th day 
Praanan    
Abaanan
  
   
Samaanan    
Udhaanan    
Viyaanan    
Naagan    
Koorman    
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Kirukaran    
Devathathan    
Dhananjeyan    
 
B) PITHAM:   
 0th day 12th day 24th day 
Anarpitham 
  
   
 Prasakam    
Ranjakam    
Aalosakam    
Saathakam    
 
C) KABAM: 
 0th day 12th day 24th day 
Avalambagam    
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Kilethagam    
Pothagam    
Tharpagam
       
   
Santhigam
  
   
  
13. SEVEN DHATHUS: (7 SOMATIC COMPONENTS)  
 0th day 12th day 24th day 
Saaram 
[Chyme] 
   
Senneer 
[Blood]  
   
Oon [Muscle]    
Kozhuppu [Fat]    
Enbu [Bones]    
Moolai 
[Bonemarrow] 
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Sukkilam/Suron
itham [Genital 
discharges] 
   
 
 
14. SYSTEMIC EXAMINATION: 
 0th day 12th day 24th day 
LOCOMOTOR 
SYSTEM 
   
CARDIO 
VASCULAR  
SYSTEM 
 
 
  
RESPIRATORY 
SYSTEM      
 
 
  
GASTRO 
INTESTINAL 
 SYSTEM    
 
 
  
CENTRAL  
NERVOUS  
SYSTEM        
 
 
  
UROGENITAL 
SYSTEM 
   
ENDOCRINE  
SYSTEM 
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15. GENERAL EXAMINATION: 
 0th day 12th day 24th day 
Height (cms)    
Weight (kg)    
Temperature(°F)       
Pulse rate (per min)    
Heart rate (per min)    
Respiratoryrate(per min)    
Blood pressure(mm/Hg)    
Pallor    
Jaundice    
Cyanosis    
Lymphadenopathy    
Pedal edema    
Clubbing    
Jugular vein pulsation    
 
16. CLINICAL SYMPTOMS 
S.NO CLINICAL  SYMPTOMS  0 th day       12th day                              24th day     
1. Acute Pain present in 
shoulder  joints 
   
2. Swelling present in shoulder 
joints 
   
3. benumbed feeling of 
shoulder joint 
   
4. Restricted movements 
(Fully/Partial/No) 
   
5. Minimal tenderness    
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Clinical examination of shoulder  joint   
I. INSPECTION               
SNO  0th day 12th day 24th day 
1 Attitude:    
2 Shoulder joint 
swelling 
   
3 Skin over the 
shoulder  joints 
   
4 Muscle wasting     
 
        II PALPATION 
SNO  0th day 12th day 24th day 
1 Tenderness    
2 Local heat    
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III. MOVEMENTS 
A. HEALTH ASSESSMENT QUESTIONNAIRE: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date :      
Station: 
 
Signature of the Investigator: 
 
 
Signature of the Lecturer:                                                       Signature of the HOD 
                                           
 
SNO  0th day 12th day 24th day 
1 
 
 
 
 
 
 
 
 
 
2 
 
 PAIN 
A. Onset: Sudden/Gradual   
   
B. Early morning  
Stiffness (Present/absent) 
   
C. Nature of pain                                             
(Mild/ Moderate/ Severe)                                                                                                     
  
D. Aggravating   factor-     
     Movement  (Yes/No) 
   
E. Relieving factor –Rest 
    (Yes/No) 
   
G. Tenderness 
     (Present/absent) 
   
 Restriction:  (Fully/Partial/No)  
 Shoulder  joints 
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AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   POTHUMARUTHUVAAN  
OPEN CLINICAL TRIAL TO ASSESS THE 
THERAPEUTIC EFFICACY OF THE SIDDHA DRUG  PARANGIPATTAI  RASAYANAM  &  LASUNATHY  
THAILAM   in  KUMBAVATHAM ( PERI ARTHRITIS SHOULDER ) 
                                                                            FORM III 
  LABORATORY INVESTIGATION ON ENROLLMENT AND  
       CONCLUSION OF TRIAL 
 
 
1. OP/IP No: ________     2.S. No:                                                3.Reg no:  32101208/2012-13 
4. Name: ________________                   5. Age:   _______ years      6. Gender: M/F    
 
 
 
 
 
 
 
BLOOD INVESTIGATION NORMAL VALUES 
BEFORE 
TMT 
 
AFTER TMT 
HB( gms%) 
M:13-18 
W:11-16 
  
 
T.RBC(milli/cu.mm) 
M:4.5-6.5 
W:3.5-5.5 
  
 
ESR (mm) 
½ hr. -   
1 hr. 
M:0-10 
W:0-20 
  
T.WBC (/cu.mm)       4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
Monocytes 2-10   
Esonophils 1-6   
Basophils 0-1   
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Blood Investigation 
Normal 
Values 
BeforeTMT 
Date: 
After TMT  
Date 
Blood 
glucose 
(mg/dl) 
Fasting 80-120   
PP <130   
Lipid 
profile 
(mg/dl) 
Serum cholesterol 150-250   
HDL 30-60   
LDL Upto 130   
VLDL 40   
TGL Upto 160   
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
Serum Uric acid 
M:3-9 
W: 2.5-7.5 
  
LFT 
(mg/dl) 
Total bilirubin 0.3-1   
Direct bilirubin 0.1-0.3   
Indirect bilirubin 0.2-0.8   
Serum total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.5   
Serum calcium 9-11   
Serum phosphorous 2-5   
SGOT (IU/L) 6-18   
SGPT (IU/l) 3-26   
Alkaline 
phosphatase (kingÅ 
units) 
3-12   
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Specific investications : 
o X - Ray of affected Shoulder  joints (AP and  supero - inferior view of shoulder joint )  
  
ECG : 
 
Date :      
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                        Signature of the HOD 
 
Other investigation 
Before TMT  
Date: 
After TMT  
Date: 
RA factor   
CRP   
URINE INVESTIGATION Before TMT(with Date) After TMT (With Date) 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
MOTION TEST   
Ova   
Cyst   
Occult blood   
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AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   POTHUMARUTHUVAM 
A CLINICAL TRIAL TO ASSESS THE  THERAPEUTIC  EFFICACY PARANGIPATTAI 
RASAYANAM  &  LASUNATHY  THAILAM   in  KUMBAVATHAM  ( PERI ARTHRITIS 
SHOULDER ) 
                                         FORM IV –A (DRUG COMPLIANCE FORM) 
S. NO:                OPD/IPD NO  :                     NAME :                                        REG NO: 32101208/2012-13 
Name Of The Drug : PARANGIPATTAI RASAYANAM (INTERNAL ) &  LASUNATHY  
THAILAM  (EXTERNAL ) 
Drugs issued:  (Nos)                                                                       Drugs issued:                  (Nos) 
Drugs returned:              (Nos)                                                                       Drugs returned:    (Nos)   
  
Date :                  
Station: 
 
Signature of the Investigator: 
Signature of the Lecturer:                                                        Signature of the HOD 
S.NO DATE 
DRUG TAKEN TIME 
MORNING/TIME EVENING/TIME 
Day 1      
Day 2      
Day 3      
Day 4      
Day 5      
Day 6      
Day 7      
Day 8      
Day 9      
Day 10      
Day 11      
Day 12      
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                                                   AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   POTHUMARUTHUVAM 
A CLINICAL TRIAL TO ASSESS THE THERAPEUTIC EFFICACY PARANGIPATTAI 
RASAYANAM  &  LASUNATHY  THAILAM   in  KUMBAVATHAM( PERI ARTHRITIS 
SHOULDER ) 
                                         FORM IV –C (DRUG COMPLIANCE FORM) 
S. NO:                OPD/IPD NO  :                     NAME :                                        REG NO: 32101208/2012-13 
Name Of The Drug : PARANGIPATTAI RASAYANAM (INTERNAL ) &  LASUNATHY  
THAILAM  (EXTERNAL ) 
Drugs issued:  (Nos)                                                                       Drugs issued:                  (Nos) 
Drugs returned:              (Nos)                                                                       Drugs returned:    (Nos)   
 
 
 Date :                
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                        Signature of the HOD 
DAYS 
                 DATE  
 
DRUG TAKEN TIME 
MORNING/TIME EVENING/TIME 
Day 13      
Day 14      
Day 15      
Day 16      
Day 17      
Day 18      
Day 19      
Day 20      
Day 21      
Day 22      
Day 23      
Day 24      
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A CLINICAL TRIAL TO ASSESS THE THERAPEUTIC EFFICACY PARANGIPATTAI RASAYANAM  &  
LASUNATHY  THAILAM   in  KUMBAVATHAM   ( PERI ARTHRITIS SHOULDER ) 
 
                                                 FORM IV-E 
                                            WITHDRAWAL FORM 
 
 S. NO: --------------------                         OPD/ IPD NO: --------          REG  NO: 32101208/2012-13 
NAME:  ------------------                          AGE: --------                           GENDER: M/F 
DATE OF TRIAL COMMENCEMENT: ----------------------- 
DATE OF WITHDRAWAL FROM TRIAL: ------------------- 
REASONS FOR WITHDRAWAL: 
· Long absence at reporting :                                        Yes/ No 
· Irregular treatment:                                                     Yes/ No 
· Shift of locality :                                                            Yes/No 
· Increase in severity of symptoms:                             Yes/No 
· Development of severe adverse drug reactions:     Yes/No 
 
 
Date :      
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                        Signature of the HOD 
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LASUNATHY  THAILAM   in  KUMBAVATHAM  ( PERI ARTHRITIS SHOULDER ) 
 
 
                                                                    FORM –IV-F 
                                                            ADVERSE REACTION FORM 
 Reg No:32101208/2012-13 
Serial No:                                                                                                          OP/IP No: 
Name:                                                             Age:                                          Gender:  M/F    
Date of trial commencement: 
Date of the adverse reaction occur; 
Time: Description of Adverse reaction: 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
                                           
 
                                                                          
 
 
 
 
 
                       
                        
                                   
 178 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
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RASAYANAM  &  LASUNATHY  THAILAM   in  KUMBAVATHAM   ( PERI ARTHRITIS 
SHOULDER ) 
FORM IV D 
     DIETARY ADVICE FORM 
· ¸¡ö¸û 
                     ¸ò¾Ã¢À¢ïÍ,ÓÕí¨¸À¢ïÍ,,«Å¨ÃÀ¢ïÍ,À¢Ãñ¨¼ Ð¨ÅÂø  
¬¸¢Â¨Å §º÷ì¸ §ÅñÎõ. 
· ¸£¨Ã¸û: 
                    ¦À¡ýÉ¡í¸ñ½¢,ãì¸¢Ãð¨¼,àÐ§Å¨Ç, 
                    ÓÕí¨¸ £¸¨Ã,¸È¢§ÅôÀ¢¨Ä, Ó¼ì¸Úò¾¡ý, 
                    «Ú¸£¨Ã, ¸Ã¢º¡¨Ä ¬¸¢Â¨Å §º÷ì¸ §ÅñÎõ. 
· ÀÆí¸û:  
                    Á¡Ð¨Ç,¬ôÀ¢û, ÀôÀ¡Ç¢, ¬ÃïÍ, §ÀÃ£î¨º, «ò¾¢, 
                             ¿¡Åø ,¬¸¢Â¨Å §º÷ì¸ §ÅñÎõ. 
· «¨ºÅõ: 
                    ¦ÅûÇ¡ðÎì¸È¢, ¸¡¨¼, º¢Ú þÈ¡ø Á£ ý  ¸ò¾¢Ã¢ì¸¡ö,  
                      «Å¨Ãì¸¡ö, Ó¾Ä¢Â ¦À¡Ã¢Âø¸§Ç¡Î ÜðÊ ¾ÃÄ¡õ. 
                    ÐÅÃõ ÀÕôÒ Ãºõ §º÷ì¸ §ÅñÎõ. 
 
          ·  ®ÃÁ¢øÄ¡ ¾¨ÃÂ¢Öõ, ÀÎì¨¸Â¢Öõ ÀÎò¾ø §ÅñÎõ, 
 ·  ÌÇ¢÷ ¸¡üÚ ÀÎõÀÊÂ¡É þ ¼ò¾¢ø þÕôÀ¨¾ ¾Å¢÷ì¸×õ 
 
§º÷ì¸ Ü¼¡¾¨Å¸û:   
                                         
·  Í¨Ã                             ¯ôÒ   
·  âº½¢                            ÒÇ¢ôÒ     
· ¦ÅûÇÃ¢ì¸¡ö                «¾¢¸ ¨¸ôÒ     
· Ò¼¨Ä                           «¾¢¸ ¸¡÷ôÒ     
· À£÷ìÌ                            Áó¾ô ¦À¡Õû   
·  ¦Á¡î¨º                       ¦ÅüÈ¢¨Ä,À¡ìÌ       
· ¸¡Ã¡Á½¢                       Ò¨¸Â¢¨Ä          
· ¯ÙóÐ                          ÁÐ «ÕóÐ¾ø 
                ·  ¦¸¡ûÙ,                       ¦Àñ§À¡¸õ 
·  ¸ÎÌ                             
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      ேதசிய சி த ம   வ நி வன , ெச ைன- 47 
                        அேயா திதாச  ப  த  ம   வமைன 
    பவாத ேநா  கான சி த ம   கள  ( பற கி ப ைட ரசாயன  ம    
இல னாதி ைதல  ) ப க     திறைன  க டறி   ம   வ ஆ வ கான ஒ  த  
ப வ                                 
 
ஒ  த  ப வ  
 
 
நா  ேம  றிய தகவ  ப வ ைத ப    அ ல  ப  க ேக    ெகா ேட . இ  
ெதாட பான வ ள க கைள   ேக   ெத   ெகா ேட .எ த வ த வ    தலி றி 
எ  ெசா த வ  ப தி  ேப   எ ைன இ த ஆரா  சி   உ ப  த எ  
  மனேதா    யனநிைனேவா   ச மத  ெத வ கி ேற . என   வ  ப  
இ லாத ப ச தி  இ த ஆரா  சிய  இ    எ ைன எ ேபா  ேவ  மானா   
வ வ   ெகா    உ ைமைய ெப   ேள  எ பைத   அறிேவ . 
 
 
  
 
 
 
 
ேததி :                                                      ைகெயா ப  
 
இட  :                                                     ெபய  : 
 
 
ேததி                                         சா சி கார  ைகெயா ப     : 
 
இட  :                                        ெபய        :      
                                                  உற  ைற       :                                           
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                                    NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
    AYOTHIDASAR PANDITHAR HOSPITAL 
           DEPARTMENT OF   POTHUMARUTHUVAM 
FORM IV C 
 
PRE CLINICAL CLINICAL STUDY ON the KUMBAVAATHAM ( PERIARTHRITIS 
SHOULDER ) and the drug of choice is  PARANGIPATTAI  RASAYANAM ( internal )  and  
LASUNATHY  THAILAM   ( external ) 
 
CERTIFICATE OF CONSENT 
 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to  ask questions about it and any questions I have asked have been 
answered to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical  care”. 
 
"I have received a copy of the information sheet/consent form". 
Date:  
 
Signature of the participant 
 
 
In case of illiterate participant 
 
             “I have witnessed the accurate reading of the consent form to the potential 
participant, and the  individual has had the opportunity to ask questions. I confirm that 
the individual has given consent freely.”                                                   
 
 
 
Date: 
 
 
 Signature of a witness : 
         Left thumb Impression of the   
          Participant     
 (Selected by the participant bearing no connection with the survey team) 
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                                            NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   POTHUMARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON KUMBA VAATHAM  (Peri Arthiritis 
Shoulder) PARANGIPATTAI RASAYANAM (Internal), LASUNATHY 
THAILAM(External) 
                   FORM IV –B (INFORMATION SHEET)  
Part – A Information Sheet 
 
I,  Dr.V.VITHYAPATHI studying M.D(S) in National Institute of Siddha, Chennai. KUMBA 
VAATHAM is a disease affecting the morbidity and causing discomfort to the person. This 
condition is being treated in NIS with many Siddha formulations. As a part of M.D(S) research 
programme and developing new efficacious medicine, we propose to study the 
PARANGIPATTAI RASAYANAM (Internal), LASUNATHY THAILAM(External) 
formulations for treating the condition. This formulation has been mentioned in Siddha literature 
and empirical evidence with contemporary tools is required for documentation. You can receive 
medicines free of cost. The duration of treatment period is 24 days. You have to visit NIS once in 
every 12 days and collect the drugs for 12 days. The diagnosis tests will be carried out at free of 
cost. We will assess the effect of treatment after completions of  days of treatment using clinical 
and laboratory parameters. 
 
In this regard, we need to ask few questions. We will maintain confidentiality of your comments 
and data obtained from you. There will be no risk of disclosing your identity and no physical, 
psychological or professional risk is involved by taking part in this study.  
 
Taking part in this study is voluntary. No compensation will be paid to you for taking part in this 
study. You can choose not to answer any specific question. There is no specific benefit for you if 
you take part of in this study, but you will be under our clinical monitoring and specific attention 
will be given for your help. Taking part in this study may be of benefit to the community, as it 
may help us to develop medicine for Kumba Vaatham. In case of any adverse symptoms during 
the treatment passing loosey stools,irritation in the stomach , indigestion  which is expected for 
few patients during the treatment, shall be reported to PIs and care will be taken in NIS for relief. 
You can withdraw from the study at the midst of treatment period, if you are not interested to 
continue and you will receive our usual treatment without condition. 
 
The information we will be collected in the study, will remain between you and the principal 
investigator. We will ask you a few questions through a questionnaire. We will not write your 
name on different forms which send to different investigating / analysis sections and we will use a 
code instead given by principal investigator. Only the principal investigator will know the key to 
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this code which will be kept in safe custody. If you agree to be the participant in this study, you 
will be screened as per the study protocol. 
 
If you wish to find out more about this study before taking part, you can ask me all the questions 
you want or contact Dr.V.VITHYAPATHI, P.G  scholar cum principal investigator of this study, 
attached to the National Institute of Siddha, Chennai(Mobile No. 9080180323). You can also 
contact the chairman / Member Secretary of ethics committee, National Institute of Siddha, 
Chennai-600047, Tel No.: 914422411611, for rights and participation in the study.  
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É 47 
«§Â¡ò¾¢¾¡º÷ ÀñÊ¾÷ ÁÕòÐÅÁ¨É 
ÌõÀÅ¡¾ §¿¡öì¸¡É º¢ò¾ ÁÕó¾¢ý ÀÈí¸¢ôÀð¨¼ þÃº¡ÂÉõ and þÄÍÉ¡¾¢ 
¨¾Äõ ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ  ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
 
FORM IV ¾¸Åø ÀÊÅõ 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷ : Dr.§Å.Å¢òÂ¡À¾¢ 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷  : §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
      ¾¡õÀÃõ º¡É¼§¼¡Ã¢Âõ 
  ¦ºý¨É- 47 
Dr.§Å.Å¢òÂ¡À¾¢ ¬¸¢Â ¿¡ý §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕ ¢¸§Èý. 
ÌõÀÅ¡¾õ ±ýÛõ §¿¡Â¡ÉÐ §¾¡û ãðÎ¸¨Ç À¡¾¢ìÌõ §¿¡Â¡Ìõ. þó§¿¡Â¡ÉÐ 
§¾¡ûÀð¨¼, ¨¸ Ó¾Ä¢Â þ¼í¸Ç¢ø ÅÄ¢, ¿£ðÊ Á¼ì¸ ÓÊÂ¡¨Á, ¬ ¢¸Â ÌÈ¢Ì½í¸û ¸¡Ïõ. 
þó§¿¡öìÌ §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ÀÄ º¢ò¾ ÁÕóÐ¸û ÀÂýÀÎò¾ôÀðÎ ÅÕ¸¢ýÈÐ. 
º¢ò¾ ÁÕòÐÅ Àð¼ §ÁüÀÊôÀ¢ø, ¬öÅ¢ý ´Õ ÀÌ¾¢Â¡¸ Ò¾¢Â ÁÕóÐ¸¨Ç ÀÂýÀÎòÐõ 
§¿¡ì¸¢ø þó§¿¡öìÌ ÀÈí¸¢ôÀð¨¼ þÃº¡ÂÉõ ÅÆí¸ ÀÃ¢óÐ¨Ã ¦ºö¸¢§È¡õ. þó¾ ÁÕó¾¢ý 
¦ºöÓ¨È, «Ç×, «ÛÀ¡Éõ ÁüÚõ ÁÕòÐÅ ÀÂý¸û «¨ÉòÐõ «í £¸¸Ã¢ì¸ôÀð¼ º¢ò¾ 
ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûÇÐ. ±ó¾Å¢¾ ¸ð¼½ÓÁ¢ýÈ¢ ¾¡í¸û þó¾ ÁÕó¾¢¨É 
¦ÀüÚì¦¸¡ûÇÄ¡õ. þó¾ ¬öÅ¢ø ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äõ 24 ¿¡ð¸û ¬Ìõ. ¦ÅÇ¢ 
ÁÕó¾¡¸ þÄÍÉ¡¾¢ ¨¾Äõ 50 Á¢Ä¢ 24 ¿¡ð¸ÙìÌ §¿¡ÔûÇ þ¼í¸Ç¢ø ¦ÅÇ¢§Â ¾¼Å 
§ÅñÎõ. ¦ÅÇ¢ §¿¡Â¡Ç÷¸û 12 ¿¡ð¸ÙìÌ ´Õ Ó¨È ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. 24 
¿¡ð¸û ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äõ ÓÊó¾ À¢ÈÌ §¿¡öì¸¡É ÌÈ¢Ì½í¸û ÁüÚõ ¬öÅ¸ 
ÀÃ¢§º¡¾¨É¸û þÅüÈ¢ý ÓÊ×¸Ç¢ý «ÊôÀ¨¼Â¢ø ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢Èý ¸ñ¼È¢ÂôÀÎõ. 
þó¾ ¬ö× ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç ¾í¸Ç¢¼õ §¸ð¸ þÕì¸¢§Èý. ¾í¸Ç¢¼Á¢ÕóÐ 
¦ÀÈôÀÎõ ¸ÕòÐì¸û ÁüÚõ ÌÈ¢ôÒ¸û «¨ÉòÐõ ¿õÀ¢ì¨¸Â¡¸ À¾¢× ¦ºöÂôÀÎõ.þó¾ 
¬öÅ¢ø ¾í¸¨Ç ¯ðÀÎò¾¢ì¦¸¡ûÅ¾¢ý ãÄõ ±ó¾ Å¨¸Â¢Öõ À¡¾¢ôÒìÌûÇ¡¸Á¡ðË÷¸û ±É 
¯Ú¾¢ «Ç¢ì ¢¸§Èý.      
±ó¾Å¢¾ ÅüÒÚò¾ÖÁ¢ýÈ¢, þó¾ ¬öÅ¢ø Àí§¸ü¸×õ, þó¾ ¬ö× ºõÀó¾Á¡¸ §¸ð¸ôÀÎõ 
§¸ûÅ¢¸ÙìÌ À¾¢ø ÜÈ×õ ¾í¸ÙìÌ ÓØ Í¾ó¾¢Ãõ «Ç¢ì¸ôÀÎ¸¢ÈÐ. þó¾ ¬öÅ¢ø 
Àí§¸üÀ¾üÌ ±ó¾ ºýÁ¡ÉÓõ ÅÆí¸ôÀ¼Á¡ð¼¡Ð.  ¬É¡ø, ¬ö× ÓØÅÐõ ±ÉÐ 
§ÁüÀ¡÷¨ÅÂ¢Öõ, ¾í¸û ¯¼ø¿Äý ÌÈ¢ò¾ ¾É¢ ¸ÅÉò¾¢Öõ ¬ö× §Áü¦¸¡ûÇôÀÎõ. ÌõÀÅ¡¾ 
§¿¡öì¸¡É Ò¾¢Â ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò¾¢È¨É ºã¸ò¾¢üÌ ¯½÷òÐõ Å¨¸Â¢ø þó¾ ¬ö× 
§Áü¦¸¡ûÇôÀÎ¸¢ÈÐ, þó¾ ¬öÅ¢ø, ÁÕóÐ ¯ð¦¸¡ûÙõ ¸¡Äò¾¢ø ÅÂ¢üÚÅÄ¢, «Êì¸Ê ÁÄõ 
¸Æ¢¾ø, ¯ñ¼ ¯½× ¦ºÃ¢Â¡¨Á,§À¡ýÈ Á¡ÚÀð¼ ÌÈ¢Ì½í¸û ¦¾¡¼÷óÐ þÕìÌõ Àðºò¾¢ø, 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É ±ýÉ¢¼õ ¦¾Ã¢Å¢ì¸ôÀðÎ, §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø «¾üì¸¡É 
¾£÷× ÅÆí¸ôÀÎõ. þó¾ ¬öÅ¢¨Éò ¦¾¡¼Ã ¾í¸ÙìÌ Å¢ÕôÀõ þø¨Ä¦ÂÉ¢ø, ±ô¦À¡ØÐ 
§ÅñÎÁ¡ÉÖõ ¬öÅ¢ý þ¨¼Â¢ø Å¢Ä¸¢ì¦¸¡ûÇ×õ, ÁÕòÐÅÁ¨ÉÂ¢ø ÅÆí¸ôÀÎõ 
þó§¿¡öì¸¡É ÅÆì¸Á¡É ÁÕóÐ¸¨Ç ¦ÀüÚì¦¸¡ûÇ×õ «È¢×Úò¾ôÀÎ ¢¸È£÷¸û. 
þó¾ ¬öÅ¢ø §º¸Ã¢ì¸ôÀÎõ Å¢ÀÃí¸û «¨ÉòÐõ ¾í¸ÙìÌõ Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É 
±ÉìÌõ þ¨¼Â¢ø þÃ¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ. §¸ûÅ¢ À¾¢ø ÅÊÅò¾¢ø ¾í¸Ç¢¼õ §¸ûÅ¢¸û 
§¸ð¸ôÀÎõ. «¨ÉòÐô ÀÊÅí¸Ç¢Öõ ¾í¸Ç¢ý ¦ÀÂ÷ ¾Å¢÷ì¸ôÀðÎ ¬öÅ¡ÇÃ¡ø ¾í¸Ùì¦¸É 
¾É¢ì ÌÈ¢Â£Î ÅÆí¸ôÀÎõ. «ó¾ì ÌÈ¢Â£Î ¬öÅ¡ÇÕìÌ ÁðÎ§Á ¦¾Ã¢ó¾¾¡¸ þÕìÌõ. ¿£í¸û 
þó¾ ¬öÅ¢ø Àí§¸ü¸ Å¢ÕôÀôÀð¼¡ø, Óý§É¡ð¼ ¬ö× ¾¸Åø ÀÊ §¾÷× ¦ºöÂôÀÎÅ£÷¸û.  
¿£í¸û þó¾ ¬öÅ¢ø Àí§¸üÌõ Óý, þó¾ ¬öÅ¢¨Éô ÀüÈ¢Â §ÁÖõ Å¢ÀÃí¸û ¦ÀÈ 
§ÅñÎ¦ÁÉ Å¢ÕôÀôÀð¼¡ø, þó¾ ¬öÅ¢ý Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ÁüÚõ §¾º¢Â º¢ò¾ 
ÁÕòÐÅÁ¨É, Àð¼ §ÁüÀÊôÒòÐ¨È Á¡½Å÷ Dr.§Å.Å¢òÂ¡À¾¢ ¬¸¢Â ±ý¨É 9080180323 ±ýÈ 
±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ. §ÁÖõ, ¿£í¸û þó¾ ¬öÅ¢ø, ¯í¸ÇÐ Àí§¸üÒ ÁüÚõ ¯Ã¢¨Á 
ÀüÈ¢ ¦¾Ã¢óÐ ¦¸¡ûÇ §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨É, ¾¨ÄÅ÷/¦ºÂüìÌØ ¯ÚôÀ¢É÷ «Å÷¸¨ÇÔõ 
91-44-22411611 ±ýÈ ±ñ½¢ø ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ.   




Albumin Fasting 
Sugar
PP Sugar Deposits Ova Cyst Occult Blood
1 C84939 42/M - - - 1.2 - - -
2 C79224 45/F
3 C78976 44/M - - - 1.2 - - -
4 C38379 36/F - - - - - -
5 C78090 40/M - - - - - -
6 C74874 56/M - - - - - -
7 C76462 49/F - - - - - -
8 C83792 60/M - - - - - -
9 C93208/4115 40/F - - - - - -
10 C94303/4149 45/F - - - - - -
11 C90904/4113 34/F - - - - - -
12 C92197/4112 34/F - - - - - -
13 C90799/4114 40/F - - - - - -
14 C83614/4119 46/F - - - - - -
15 C94000/54044 60/M - - - - - -
16 C63281 32/M - - - - - -
17 C85918/4049 50/F - - - - - -
18 B25276 50/F - - - - - -
19 C75719 57/M - - - - - -
20 C58864 49/F - - - - - -
21 C4046 58/F - - - - - -
22 C82201 58/F - - - - - -
23 C87544 56/F - - - - - -
24 C86291/4003 45/F - - - - - -
25 A27878 55/F - - - - - -
26 C86287/4004 53/F - - - - - -
27 C76913 27/M - - - - - -
28 C93202 50/M - - - - - -
29 C92105 50/M - - - - - -
30 C77772 57/F - - - - - -
31 B29219 40/F - - - - - -
32 C59987 35/M - - - - - -
33 C81598 47/M - - - - - -
34 C89682 47/F - - - - - -
35 C79108 34/F - - - - - -
36 C90700 37/M - - - - - -
37 C83650 33/M - - - 1.2 - - -
38 C80190 40/M NIL NIL NIL - - -
39 A36870 35/F NIL NIL NIL - - -
40 C82416 51/F NIL - NIL - - -
S.No OP/IP No A/S
URINE MOTION




Albumin Fasting 
Sugar
PP Sugar Deposits Ova Cyst Occult Blood
1 C84939 42/M NIL NIL NIL - - -
2 C79224 45/F NIL NIL NIL - -
3 C78976 44/M NIL NIL NIL - - -
4 C38379 36/F NIL NIL NIL - - -
5 C78090 40/M NIL NIL NIL - -
6 C74874 56/M NIL NIL NIL - - ABSENT
7 C76462 49/F NIL NIL NIL - - -
8 C83792 60/M
9 C93208/4115 40/F NIL NIL NIL - - -
10 C94303/4149 45/F NIL NIL NIL - - -
11 C90904/4113 34/F NIL NIL NIL - - -
12 C92197/4112 34/F NIL NIL NIL - - -
13 C90799/4114 40/F NIL NIL NIL - - -
14 C83614/4119 46/F NIL NIL NIL - - -
15 C94000/54044 60/M
16 C63281 32/M NIL - NIL - - -
17 C85918/4049 50/F NIL NIL NIL - - -
18 B25276 50/F NIL NIL NIL - - -
19 C75719 57/M NIL NIL NIL - - -
20 C58864 49/F NIL NIL NIL NIL NEGATIVE ABSENT
21 C4046 58/F NIL NIL NIL - - -
22 C82201 58/F NIL NIL NIL - - -
23 C87544 56/F
24 C86291/4003 45/F NIL NIL NIL NIL NEGATIVE ABSENT
25 A27878 55/F NIL NIL NIL - - -
26 C86287/4004 53/F
27 C76913 27/M NIL - NIL - - -
28 C93202 50/M
29 C92105 50/M NIL NIL NIL - - -
30 C77772 57/F
31 B29219 40/F NIL NIL NIL - - -
32 C59987 35/M NIL - NIL - - -
33 C81598 47/M
34 C89682 47/F
35 C79108 34/F NIL NIL NIL - - -
36 C90700 37/m
37 C83650 33/M
38 C80190 40/M NIL NIL NIL - - -
39 A36870 35/F NIL NIL NIL - - -
40 C82416 51/F
S.No OP/IP No A/S
URINE MOTION
  

 
 
  
